The Research — Pain Resolution Therapy

Essentials

Why Pain Persists After Healing

The Predictive Brain

Understanding the brain as a prediction machine — and what that means for chronic pain.

0:00—

A fundamental assumption underlying most medical approaches to pain is that pain reflects the current state of the body's tissues. We expect pain intensity to correspond to the degree of injury or pathology. We assume that when tissues heal, pain should disappear. We believe that imaging studies showing structural abnormalities explain why someone hurts. These assumptions, intuitive and deeply embedded in both medical training and lay understanding, are systematically contradicted by the evidence. Pain intensity correlates poorly with tissue pathology. Imaging findings often bear little relationship to symptoms. People with severe structural abnormalities on MRI may have no pain at all, while others with normal scans experience debilitating suffering. Pain spreads to regions far from any original injury. It migrates from one body part to another with no clear anatomical logic. It fluctuates dramatically based on context, expectation, and emotional state in ways that make no sense if pain were simply reporting tissue damage. These patterns have puzzled clinicians for decades. The explanation lies in reconceptualizing pain not as a readout of tissue state but as a prediction generated by the brain.

The predictive brain framework, also called predictive coding or Bayesian brain theory, represents one of the most important conceptual advances in neuroscience over the past two decades. It applies not only to pain but to all aspects of perception and action. The core idea is that the brain does not passively receive sensory information and construct perception from the bottom up. Instead, the brain is fundamentally a prediction machine. It constantly generates predictions about what sensory signals should be arriving based on its internal models of the world, built from past experience. These predictions flow downward from higher cortical areas to lower sensory processing regions. Incoming sensory signals flow upward. At every level of processing, the brain compares predictions with actual sensory input. The difference between predicted and actual signals is called prediction error. When prediction errors are large, the brain updates its models. When predictions closely match incoming signals, the brain suppresses those signals as expected and unremarkable. Conscious perception emerges not from raw sensory data but from the brain's best inference about what is causing those data, given prior beliefs and current context.

Applied to pain, predictive coding transforms our understanding. Pain is not constructed primarily from nociceptive input ascending from the body. Pain is constructed primarily from the brain's prediction about whether there is tissue damage or threat requiring protection. Nociceptive signals from the body are just one source of evidence the brain considers. Other sources include visual information about the body part, memories of past experiences with similar sensations, beliefs about what the sensations mean, emotional state, attention, and contextual cues. The brain weights these various sources of information according to their reliability, integrating them in a Bayesian manner to arrive at its best estimate of whether threat is present. If the brain's prior expectation of pain is strong, even minimal nociceptive input will be interpreted as confirming that expectation, and significant pain will be experienced. If the brain's prior expectation is that the body is safe, even substantial nociceptive input may be down-weighted and little pain experienced. Pain, in this view, is not a faithful report of tissue state. It is an inference, a probabilistic guess about whether protection is needed.

This framework explains phenomena that are inexplicable under traditional models. Consider placebo analgesia, where a person experiences substantial pain relief after receiving an inert treatment they believe to be a powerful analgesic. Under traditional models, this is mysterious. No pharmacological agent has been administered, yet pain decreases and brain imaging shows reduced activity in pain-processing regions. Under predictive coding, placebo analgesia makes perfect sense. The belief that one has received effective treatment changes the brain's prior expectation about pain. The predicted level of pain decreases. When nociceptive signals arrive, they are compared against this lowered prediction, generating smaller prediction errors and less experienced pain. Descending pathways from prefrontal cortex and other high-level regions modulate activity in pain-processing areas to align perception with prediction. Endogenous opioid systems are engaged. Pain genuinely decreases, not through peripheral mechanisms but through top-down modulation driven by changed expectations.

Nocebo effects provide the mirror image. When people are led to expect increased pain or harm, their pain intensifies even when the physical stimulus remains unchanged. Expectations of pain bias the system toward interpreting ambiguous signals as threatening. Prior beliefs that a particular movement will cause injury heighten vigilance and amplify pain when that movement is performed. Anxiety and fear, which inherently involve predictions of future threat, shift the entire system toward heightened sensitivity. The brain, expecting danger, becomes more responsive to any signals that could confirm that expectation. This is not malingering or psychological weakness. It is the predictive brain functioning exactly as designed, weighting evidence according to priors and generating the most likely interpretation. When those priors have been shaped by repeated painful experiences, by trauma, or by frightening medical diagnoses, they bias the system powerfully toward pain.

Context exerts profound effects on pain perception through predictive mechanisms. In experimental studies, the identical noxious stimulus produces dramatically different pain ratings and brain activation patterns depending on contextual cues. When moderate heat is presented in a context where participants have been conditioned to expect low-intensity stimuli, it is rated as painful and activates pain-processing regions strongly. When the same moderate heat is presented in a context where participants have also experienced high-intensity stimuli, creating a relative relief context, it is rated as pleasant and produces reduced activation in pain areas with increased activity in reward-related regions. The physical stimulus is identical. The tissue state is identical. What differs is the prediction. In the relative relief context, the brain predicts high pain based on prior experience. When moderate pain arrives instead, a positive prediction error occurs. The stimulus is better than expected, engaging reward systems and reducing pain. This is not simply distraction or reappraisal. It is a fundamental shift in how sensory signals are processed based on what the brain predicted they would be.

Context effects extend to clinical pain. Patients report different pain levels in different environments, at different times of day, when engaged in different activities, and when with different people, even when the underlying tissue pathology is unchanged. These variations are not random. They reflect how contextual cues shape predictions. A context previously associated with pain triggers predictions of pain, priming the system to interpret sensations as threatening. A context associated with safety, pleasure, or distraction generates predictions of lower threat, dampening pain signals. Chronic pain patients often report that their pain is worst when they are alone, inactive, or focused on their bodies. These contexts lack competing predictions and allow pain-related predictions to dominate. Conversely, engaging activities, social connection, or contexts associated with positive outcomes can substantially reduce pain by generating competing predictions that down-weight nociceptive signals.

The relationship between structural imaging findings and pain becomes comprehensible through predictive coding. Numerous studies have documented the poor correlation between imaging abnormalities and symptoms. A landmark systematic review examining MRI findings in asymptomatic individuals without back pain found that disc bulges were present in 30 to 40 percent of people in their twenties, increasing to over 80 percent in those over sixty. Disc protrusions were found in 29 percent of twenty-year-olds and 43 percent of those over sixty. Annular fissures, disc degeneration, and facet joint arthropathy were similarly common in people reporting no pain whatsoever. More recent studies confirm that approximately 30 percent of asymptomatic individuals show lumbar disc herniation on MRI, with disc bulge being the most common finding. The majority of herniations occur at L4-L5 and L5-S1, the same levels most commonly implicated in symptomatic patients. These findings demonstrate conclusively that structural abnormalities visible on imaging are often unrelated to pain experience.

Conversely, many individuals with severe, disabling pain show minimal or no structural pathology on imaging. Their scans are read as normal or showing only mild degenerative changes typical for their age. Under a tissue-damage model, this disconnect is profoundly frustrating for both patients and clinicians. Patients feel dismissed, as if they are being told their pain is not real. Clinicians feel uncertain about diagnosis and treatment. Under a predictive coding model, the disconnect makes sense. The structural abnormalities visible on imaging may be present, but they are not driving the pain experience. What drives pain is the brain's prediction that threat is present. That prediction has been shaped by various factors including initial injury, repeated painful experiences, fear-inducing medical messaging, emotional distress, trauma history, and learned associations between certain movements or contexts and pain. The nervous system has learned to predict pain in response to sensory signals from that body region, independent of whether tissue damage is currently present.

Pain spreading patterns provide further evidence for predictive mechanisms. Referred pain, where pain is experienced in a region distant from the site of pathology, is well documented but poorly explained by peripheral models. Visceral pain from a heart attack is felt in the left arm and jaw. Kidney stones cause pain radiating to the groin. Cervical spine dysfunction produces pain in the shoulder, arm, or hand. These patterns reflect convergence of sensory afferents from different body regions onto common neurons in the spinal cord and brain, creating ambiguity about the source of signals. The brain resolves this ambiguity through prediction. Based on past experiences and learned associations, the brain infers the most likely source and location of threat. When those predictions are wrong, pain is experienced in regions with no local pathology. In chronic pain, referred pain extends further. Pain that began in the low back spreads to the buttocks, then the thighs, then the calves. Pain that started in one shoulder appears in the opposite shoulder. These spreading patterns do not follow nerve distributions or dermatomal maps. They reflect expansion of the brain's threat prediction system, where more and more body regions become associated with danger and thus with pain.

The phenomenon of mirror pain, where pain develops in a limb opposite to an injured limb, illustrates predictive mechanisms strikingly. Studies of complex regional pain syndrome document cases where pain spreads from one limb to the contralateral limb with no injury to that second limb and no anatomical pathway to explain transmission. The spreading follows patterns that suggest involvement of motor cortex representations and altered body schema rather than peripheral pathology. In one analysis of pain spread patterns, three distinct types were identified. Contiguous spread moves proximally from the initial site. Independent spread involves emergence of pain in a separate limb or body region. Mirror spread affects the homologous region of the opposite limb. None of these patterns are explained by progression of tissue damage. They reflect changes in how the brain represents the body and predicts threat across body regions. When the brain's internal model of one limb has become associated with intense threat and pain, that association can generalize to other limbs, particularly those with similar sensorimotor representations.

Inconsistent triggers and variable pain responses further reveal the role of prediction. Chronic pain patients often report that their pain is highly inconsistent. On some days, an activity that typically causes severe pain produces minimal discomfort. On other days, a movement they can usually perform without difficulty triggers intense pain. The same stimulus, the same mechanical load, the same tissue state, yet wildly different pain experiences. This variability is maddening under a tissue-damage model. If pain reflects injury, it should be consistent. Under a predictive model, variability is expected. The brain's prediction about pain is influenced by numerous factors beyond the immediate stimulus including sleep quality, stress level, emotional state, where attention is focused, what else is happening in the person's life, and subtle contextual cues. When these factors align to create high prediction of threat, pain will be intense. When they align to create low prediction of threat, the same stimulus will produce little pain. The stimulus does not solely determine the experience. The prediction does.

The timing of pain onset and resolution often defies tissue-based explanations but fits predictive models. Many chronic pain conditions begin not immediately after an injury but days, weeks, or even months later. The tissue has healed, yet pain emerges. Others report that pain persisted unchanged for years and then resolved suddenly, with no medical intervention and no change in imaging findings. These temporal patterns make no sense if pain tracks tissue state. They make sense if pain tracks learned predictions. The delayed onset pattern may reflect the time required for the brain to learn that a particular body region is dangerous, or for life stressors to accumulate to a point where the nervous system shifts into a sustained threat state. The sudden resolution pattern may reflect a moment when the person's understanding of their pain shifts, when they realize through experience that the predicted danger is not real, or when emotional or life circumstances change in ways that alter the brain's threat predictions. Pain Resolution Therapy leverages this understanding. By systematically updating predictions through reattribution, emotional processing, and behavioral experiments, the approach targets the actual mechanism maintaining pain.

Emotional and psychological states influence pain so powerfully precisely because they influence predictions. Depression involves predictions of future loss, failure, and hopelessness. Those predictions bias the entire perceptual system toward interpreting ambiguous signals as negative. Pain signals become further evidence that things are bad and getting worse. Anxiety involves predictions of future threat. An anxious brain is primed to detect danger, lowering thresholds for interpreting sensations as pain. Anger, particularly suppressed anger, maintains autonomic arousal and vigilance, keeping the nervous system in a state where pain predictions are more likely. Grief, trauma, and unresolved conflicts all shape predictions in ways that can maintain or worsen pain. These are not secondary reactions to pain. They are integral to the mechanism generating pain. When Pain Resolution Therapy helps clients identify and process suppressed emotions, it is not providing psychological support separate from pain treatment. It is directly addressing a primary driver of the predictions maintaining pain.

Learning and memory underlie the predictions that generate chronic pain. When a person experiences pain repeatedly in association with particular movements, those movements become conditioned predictors of pain. The motor system begins generating pain predictions even as the movement is planned, before any mechanical load has been applied to tissues. This explains anticipatory pain, where people hurt before they have even completed a feared movement. The pain is generated by the prediction, not by the movement itself. When pain has been experienced in multiple contexts, when medical professionals have delivered frightening diagnoses, when the person has catastrophized about their condition, the brain's pain prediction system has been trained extensively. It has learned that this body region is dangerous, that pain is likely, that protection is needed. Those learned predictions become self-fulfilling. The brain generates the pain it predicts.

Breaking this cycle requires unlearning, which is the core of neuroplasticity-based pain treatment. Pain Resolution Therapy's reattribution component teaches clients to recognize that their pain is generated by prediction rather than tissue damage. This cognitive shift alone begins to alter the weight given to different sources of evidence. Rather than interpreting pain as proof of injury, the person learns to interpret it as evidence that their brain's threat prediction system is overactive. This reframing reduces fear and catastrophizing, which are themselves predictions of future threat. The emotional processing component addresses the experiences and conflicts that have shaped threat predictions. Suppressed anger signals to the nervous system that danger is present but cannot be directly confronted. Processing that anger resolves the threat signal. Unprocessed trauma creates predictions that the world is dangerous and that the person is vulnerable. Trauma work updates those predictions. The behavioral experiment component provides new evidence to update predictions. When a person engages in a feared movement and discovers that the predicted catastrophic pain does not occur, prediction error is generated. The brain's model updates. With repeated experiences of safety during previously avoided activities, predictions shift. Movements that were predicted to cause harm become predicted as safe. Pain decreases not because tissues have changed but because predictions have changed.

The predictive brain framework also explains why pain can function as communication about emotional and relational needs. If pain is a prediction about threat, and if the nervous system can detect threats that are not physical but emotional, social, or existential, then pain can signal those threats. A person who has never learned to recognize or express their own needs may have no conscious access to the information that they are overextended, undervalued, or living in conflict with their values. But their nervous system detects the threat. It signals danger through the only language it knows: pain. The pain is not imaginary. It is a real protective response to real threat. The threat simply is not tissue damage. It is emotional harm, boundary violation, role conflict, or suppressed self. Pain Resolution Therapy's conflict-resolution component addresses these threats directly. When the person identifies that their pain worsens when they cannot say no, when they suppress their authentic feelings, or when they are in relationships that violate their boundaries, the mechanism becomes clear. The pain is the nervous system's prediction that danger is present under those conditions. Resolving the conflict, changing the role pattern, or setting the boundary updates the prediction. The danger signal is no longer needed. Pain can resolve.

The predictive brain model transforms how we understand chronic pain persistence. Pain does not persist because tissues remain damaged. It persists because the brain continues to predict threat. That prediction is maintained by multiple factors including learned associations between sensations and pain, fear and catastrophizing that bias interpretations toward threat, suppressed emotions that maintain autonomic arousal, unresolved conflicts that keep the nervous system on guard, and lack of corrective experiences demonstrating safety. All of these factors are modifiable. This is why interventions targeting the brain rather than the tissues can produce outcomes where two-thirds of patients achieve pain-free or nearly pain-free status. Those interventions update the predictions. They teach the brain, through cognitive work, emotional processing, and behavioral evidence, that the threat it has been predicting is not present. The body is safe. Movement is safe. Sensations are not dangerous. When those predictions update, pain resolves, because the pain was always a prediction rather than a reflection of tissue state.

This framework does not deny the reality of pain or suggest it is imaginary. The pain is utterly real, as physically experienced and as neurobiologically grounded as any pain with clear peripheral pathology. What differs is the mechanism. Understanding pain as prediction explains the disconnect between imaging and symptoms, the context dependency of pain experience, the spreading and migratory patterns that defy anatomical logic, the variability and inconsistency that frustrate both patients and clinicians, and the profound influence of psychological and emotional factors. It also reveals the path to resolution. If pain is generated by predictions learned through experience, then pain can be eliminated by updating those predictions through new experience. Pain Resolution Therapy provides the structured framework for achieving that update, teaching the brain that it can stop predicting threat, that it can safely turn down the alarm, and that the body no longer requires pain as protection. The predictive brain is trainable. When trained toward threat, it generates pain. When trained toward safety, pain resolves. This is not belief or willpower. It is neuroplasticity, the same mechanism that created the pain being harnessed to eliminate it.

Why Knowledge Doesn't Equal Change

The Knowing–Doing Gap

Closing the gap between understanding pain neuroscience and actually resolving it.

0:00—

Pain neuroscience education has transformed how many clinicians think and talk about chronic pain. Instead of explaining pain solely in terms of damaged tissues, degenerating joints, or "slipped" discs, pain neuroscience education helps patients understand pain as a protective output of the nervous system, shaped by central sensitization, context, and learning. Well-delivered education can reduce fear, catastrophizing, and stigma. Patients often describe it as a revelation: "No one ever explained my pain this way before." For some, this understanding alone leads to noticeable improvement. For many others, however, the initial insight does not translate into lasting change. They know, intellectually, that their pain is coming from a sensitized system rather than a broken body, yet their pain persists. This gap between knowing and doing—between insight and lived change—is precisely why pain neuroscience education is necessary but not sufficient.

The research evidence supports this distinction. A systematic review and meta-analysis of pain neuroscience education for chronic low back pain analyzed eight randomized controlled trials including 615 participants. When PNE was delivered alone and compared with no PNE, the pooled effect on short-term pain was small and not statistically robust, with low-quality evidence. In contrast, when PNE was combined with physiotherapy interventions such as exercise, manual therapy, or motor control training, the pooled effect on short-term pain was larger and statistically significant, and the effect on disability was similarly more substantial. Moderate-quality evidence indicated that the addition of PNE to usual physiotherapy probably improves disability and pain in the short term. However, this same meta-analysis found no evidence that adding PNE to physiotherapy produced long-term improvements in pain or disability beyond usual care. The benefits were real but time-limited.

A 2023 overview of systematic reviews in the Journal of Orthopaedic & Sports Physical Therapy examined 8 systematic reviews including 30 meta-analyses of pain neuroscience education delivered alone or in combination with other interventions for chronic pain. The authors reported that in some meta-analyses, PNE (alone or combined) was more effective than control interventions for reducing pain intensity, pain catastrophizing, kinesiophobia, anxiety, and depression at some time points. However, other meta-analyses found no effect, and there were inconsistencies even between meta-analyses examining the same outcomes. All included systematic reviews were rated as having "critically low" methodological quality, and the overlap of primary trials across reviews was high. The authors concluded that it was impossible to make clear clinical recommendations for delivering pain neuroscience education based on current meta-analyses and called for higher-quality research.

Recent broader meta-analyses highlight where PNE fits best. A 2025 systematic review and meta-analysis of 19 trials in physical therapy practice found that PNE combined with rehabilitation modalities significantly reduced pain intensity and improved functionality in chronic pain patients. The average pain score decreased from 5.89 to 3.03 on a 0–10 scale, with parallel improvements in disability. The most common pairing was PNE plus therapeutic exercise. The authors concluded that integrating PNE with physical therapy appears to be an effective approach for reducing pain and improving functional outcomes. Yet they noted substantial heterogeneity across studies and recommended cautious interpretation.

Importantly, these data show PNE as a potent amplifier of other treatments, not as a standalone cure. When PNE is added to exercise, manual therapy, or cognitive-based functional interventions, outcomes often improve more than with the physical or behavioral intervention alone. But when PNE is compared to conventional education or minimal interventions on its own, the results are mixed. Several randomized trials suggest that PNE alone is not clearly superior to biomedical education on key outcomes such as pain, disability, fear-avoidance, and mood. In some trials, PNE does better on specific psychosocial scales like catastrophizing or kinesiophobia but not on primary pain or function outcomes. In others, PNE alone behaves like a sophisticated educational placebo—changing knowledge and attitudes without producing robust, consistent changes in how patients move, feel, or live.

This pattern reflects a well-known phenomenon in behavioral science: the knowing–doing gap. People can understand, in detail, what is happening and what they "should" do, yet continue behaving in the old way. Health education programs have documented this for decades: increasing knowledge about diet, exercise, or smoking does not automatically lead to behavior change. Neuroscience offers a clear explanation. Declarative knowledge (what we can state and explain) is stored and processed differently from procedural knowledge (what we actually do) and from the emotional learning that shapes threat detection. Pain neuroscience education largely targets declarative knowledge and some beliefs. Chronic pain is maintained primarily by procedural and emotional learning.

In central sensitization, the nervous system has undergone neuroplastic changes based on repeated experiences. The brain has learned that certain movements, contexts, and emotional states are dangerous and responds with protective pain. These learned associations are encoded in networks linking sensory cortex, insula, anterior cingulate, amygdala, hippocampus, and prefrontal regions. They are reinforced each time a predicted flare occurs after a feared activity or during an unresolved conflict. Changing this pattern requires new experiences that contradict the brain's predictions, not just new ideas about pain.

Pain neuroscience education can prime the system for such change. When patients learn that pain can be produced without damage, that their MRI findings are common in pain-free individuals, and that central sensitization is reversible, their fear often decreases. Catastrophizing may drop. They may become more willing to experiment with movement or emotional expression. But unless those experiments actually occur, and unless they are repeated enough to create prediction errors and new learning, the old neural patterns remain. The nervous system continues to behave according to its training, not its new intellectual curriculum.

Research on PNE in middle school students illustrates this gap and how it can be bridged. A public health trial delivered a single PNE lecture to seventh graders and compared it with usual curriculum pain education or PNE plus two booster sessions over six months. PNE alone improved pain knowledge and reduced fear-avoidance beliefs immediately, but at six-month follow-up, the group receiving PNE plus boosters showed larger positive behavioral changes: reduced pain medication use and fewer rehabilitation visits in those with pain. The added sessions likely reinforced not just knowledge but also its application in daily life. Even so, the program focused on early prevention, not on reversing entrenched chronic pain. The authors emphasized that PNE must be coupled with behavior change strategies to yield meaningful downstream outcomes.

In adults with established chronic pain, similar principles apply. Studies comparing PNE alone with PNE plus exercise, manual therapy, or cognitive-based functional therapy generally find that the combined interventions outperform PNE-only approaches on pain and disability. One trial in chronic low back pain compared pain biology education alone with the same education plus a small dose of group exercise and found no significant between-group differences on most outcomes, in part because the exercise dose was clearly insufficient. Other trials that provided more robust physical or cognitive-behavioral components alongside PNE reported superior results for the combined packages.

From a Pain Resolution Therapy perspective, this is exactly what is expected. PNE is foundational because it changes the story patients tell themselves about their pain. Without that shift, attempts to move differently, feel differently, or choose differently are constantly undermined by fear of damage. But story change alone does not rewrite the nervous system's predictive codes. For that, patients must repeatedly do things they previously avoided, feel emotions they previously suppressed, and make choices in conflicts they previously froze around—while carrying the new understanding that these actions are safe.

This is where the emotional and behavioral components of Pain Resolution Therapy come in. Reattribution uses PNE principles but anchors them in the patient's specific history and current conflicts. Instead of generic explanations about "hurt versus harm," patients map how their own pain flares track with stressors, conflicts, and suppressed emotions. Pain becomes intelligible within their life, not just within neuroscience diagrams. Emotional processing then moves beyond education to direct engagement with the feelings that have been driving protection. Patients learn to feel anger, grief, fear, and shame in their bodies, in tolerable doses, while staying present rather than dissociating or somatizing. This is not reprocessing in the sense of revisiting trauma memories step-by-step; it is allowing current emotional truth to be felt and expressed so that the nervous system no longer needs to use pain as its primary language.

Conflict resolution, focused on the Inner Conflict Circuit, addresses the chronic "I have no choice" dilemmas that keep the system in a perpetual threat state. Patients identify their central conflicts—duty versus rest, authenticity versus approval, anger versus peace-keeping—and see how these conflicts show up in their symptoms. They then design and test small, concrete behavioral experiments that move them toward a chosen, workable position in those conflicts. Each experiment is an opportunity for the nervous system to learn something PNE alone cannot teach: that life can continue, and may even improve, when they act differently. Saying no once to a non-essential demand, resting without punishing self-talk, or calmly stating a boundary provide far more powerful corrective signals to the threat system than hearing one more time that "pain does not equal damage."

These experiences close the knowing–doing gap. The patient who previously said, "I know my pain is from my brain, but it still hurts," begins to say, "I see that when I overextend myself from guilt, my pain spikes, and when I choose differently, it settles." The nervous system receives both cognitive and experiential evidence that threat has decreased. Over time, central sensitization can unwind. PNE facilitated this process by making it conceivable, but it did not achieve it on its own.

For clinicians enthusiastic about PNE, this understanding is crucial. There is a temptation, especially in busy practice, to believe that a well-delivered explanation is the main intervention. Patients are shown a few diagrams, hear about the "pain alarm," and are sent home to live differently. When they return still in pain, clinicians may feel that the model has failed or that the patient "didn't get it." In reality, the model was only partially applied. PNE should be viewed as the theoretical and motivational base on which a structured program of behavioral and emotional work is built, not as the program itself.

For patients, framing PNE as a starting point rather than a solution prevents false hope and subsequent disillusionment. Understanding why pain persists can be profoundly relieving and empowering. But it is important to convey that knowledge must be turned into new actions and new emotional experiences to retrain the system. Otherwise, patients risk internalizing the idea that "it's all in my brain" in a way that feels blaming rather than liberating.

Pain Resolution Therapy honors the contribution of PNE while correcting its overextension. It takes the best of pain neuroscience education—the clear, destigmatizing explanation of central sensitization and neuroplasticity—and couples it with targeted emotional and behavioral interventions that give the nervous system the repetition and evidence it needs to change. In doing so, it closes the knowing–doing gap and moves patients from "I understand my pain" to "My pain has changed."

Why Pharmacology Can't Solve a Neuroplasticity Problem

Pain Medications

Why analgesic drugs often fail to resolve chronic neuroplastic pain.

0:00—

Modern medicine has become extraordinarily skilled at changing chemistry. It can block receptors, open channels, modulate neurotransmitters, and alter inflammatory cascades with remarkable precision. For acute pain after surgery or injury, this pharmacological control is often lifesaving and humane. Short courses of opioids, non-steroidal anti-inflammatory drugs, and local anesthetics can dramatically reduce suffering while tissues heal. The problem arises when a tool built for short-term nociceptive pain is applied to long-term neuroplastic pain—chronic pain maintained not by ongoing tissue damage, but by changes within the nervous system itself. In that context, pain medications become a blunt instrument. They treat a complex learning disorder with chemistry alone and, unsurprisingly, they rarely solve the problem.

Chronic psychophysiologic pain is fundamentally a disorder of neural processing. Central sensitization, altered descending modulation, and maladaptive predictive coding cause normal or minor sensory input to be experienced as persistent, often severe pain. The spinal cord and brain have learned to amplify and prioritize threat signals. These changes are supported by synaptic plasticity, gene expression shifts, glial activation, and entrenched patterns of attention, emotion, and behavior. Once established, they behave less like an ongoing injury and more like a software program that keeps running in the background. Turning down the volume of nociceptive input with drugs can sometimes reduce the output of that program. But it does not rewrite the code.

The major guidelines for chronic primary pain now reflect this reality. The 2021 NICE guideline on chronic primary pain—pain that is not explained by clear ongoing tissue damage—explicitly recommends against initiating conventional analgesics, including paracetamol, NSAIDs, opioids, benzodiazepines, gabapentinoids, and local anesthetics, for this population. The reason is simple: when high-quality data are available, these medications offer little benefit and substantial harm at a population level. NICE instead recommends non-drug approaches such as exercise, psychological therapy, and, in some cases, antidepressants, which have modest evidence for improving quality of life, sleep, and distress, even in the absence of depression. Editorials summarizing the guideline emphasize that "no analgesics" are recommended for chronic primary pain because benefits "do not outweigh the risks" across the population.

Even in chronic secondary pain conditions—where there is identifiable tissue pathology such as osteoarthritis or neuropathy—the story is similar. A comprehensive analysis of neuropathic pain pharmacotherapy notes that the most effective drugs, such as duloxetine, gabapentin, and pregabalin, have numbers needed to treat in the range of 5 to 7 for 50 percent pain relief. That is, for every five to seven patients treated, one will achieve at least 50 percent reduction in pain beyond placebo; the rest will achieve less benefit or none. A large meta-analysis of neuropathic pain trials found that these numbers have worsened over time as studies have become more rigorous. The authors concluded bluntly that "only a minority of people with moderate or severe neuropathic pain achieve a clinically meaningful pain outcome" with current medications.

Data for specific drugs illustrate this minority benefit. Gabapentin, one of the most widely prescribed neuropathic agents, reduces pain scores by less than one point on a 0–10 scale on average and benefits about 15 percent of carefully selected patients, with numbers needed to treat of 6 to 8 for substantial relief. Many patients experience none of the promised benefit but do experience side effects such as dizziness, sedation, weight gain, or cognitive dulling. Pregabalin performs similarly, with NNTs around 7.2 to 7.7 for 50 percent pain relief and common adverse effects including somnolence and ataxia. Even opioids, often perceived as powerful analgesics, show surprisingly modest effects in chronic noncancer pain. A 2018 JAMA meta-analysis of 96 randomized trials involving more than 26,000 patients found that opioids reduced pain by only 0.7 cm on a 10 cm visual analogue scale and improved physical function by about 2 points on a 100-point scale compared with placebo. These statistically significant differences fall below thresholds typically considered clinically important.

Perhaps most striking is the paucity of long-term data. When researchers confined their review to trials with at least 12 months of follow-up, one systematic review of opioids for chronic noncancer pain found no eligible randomized controlled trials. The evidence base for "long-term" opioid effectiveness rests largely on uncontrolled extension studies and observational cohorts, which are prone to bias and cannot reliably distinguish drug effect from natural history or placebo. For other analgesics, most efficacy trials last 8 to 12 weeks. There is little high-quality evidence that any current pain medication provides sustained, meaningful pain relief beyond six months for a majority of chronic pain patients.

At the same time, the risks of chronic pharmacologic treatment are well documented. Opioids carry risks of dependence, overdose, endocrine dysfunction, constipation, sleep-disordered breathing, and immunomodulation. NSAIDs increase gastrointestinal bleeding, renal impairment, and cardiovascular risk, especially when used chronically. Gabapentinoids and some antidepressants cause sedation, weight gain, cognitive blunting, and in some cases, misuse or withdrawal phenomena. It is therefore unsurprising that guideline panels, when weighing small average benefits against substantial, well-characterized harms, increasingly recommend against routine long-term analgesic prescribing for chronic primary pain conditions.

One of the most concerning pharmacological phenomena in chronic pain is opioid-induced hyperalgesia. Opioid-induced hyperalgesia is defined as a state of nociceptive sensitization caused by exposure to opioids, in which patients receiving opioids become more sensitive to certain painful stimuli. Clinical reviews describe it as a paradoxical response: as opioid doses escalate, some patients report increased, more diffuse pain rather than relief. Quantitative sensory testing studies show that patients on chronic opioid therapy can exhibit decreased pain thresholds and enhanced temporal summation—physiological markers of central sensitization—compared with both chronic pain patients not on opioids and healthy controls. Systematic reviews outline how both short-term intraoperative opioid infusions and long-term maintenance therapy can, in some individuals, expand areas of hyperalgesia and allodynia.

Clinicians are advised to suspect opioid-induced hyperalgesia when opioid effects seem to wane without disease progression, when pain becomes more widespread or less like the original complaint, and when pain paradoxically worsens with higher doses. In such cases, reducing or tapering the opioid dose sometimes leads to improved pain control, a pattern inconsistent with simple tolerance and strongly suggestive of drug-induced sensitization. In other words, the very medication intended to dampen pain has, through neuroplastic mechanisms, taught the nervous system to feel more pain.

Tolerance is a related but distinct issue. With repeated exposure to opioids, receptor-level and cellular adaptations reduce drug effect, requiring higher doses to achieve the same analgesia. This leads to a familiar cycle: a patient reports that their medication "is not working anymore," the dose is increased, temporary relief follows, and then the effect fades again. Escalating doses bring escalating risks without guaranteeing better function. Evidence-based summaries of chronic opioid therapy emphasize that while some carefully selected patients may experience meaningful, sustained pain relief, the overall quality of evidence is weak and the risks of tolerance, dependence, and other adverse effects are substantial.

Even when medications do reduce pain, their impact on central sensitization is limited and often indirect. Some centrally acting drugs, including duloxetine, milnacipran, gabapentin, and pregabalin, can reduce laboratory measures of central sensitization in experimental models. They dampen hyperexcitability in dorsal horn neurons, reduce excitatory neurotransmitter release, and enhance descending inhibition. However, these effects are partial and contingent on continued drug presence. When the drug is stopped, the underlying synaptic and network changes that were shaped by years of painful experience, emotional stress, and behavioral patterns are still there unless addressed by other means.

Short-acting interventions on peripheral input, such as nerve blocks, illustrate this limitation starkly. Experimental and clinical work on perioperative nerve blocks and lidocaine infusions shows that while they can prevent the development of central sensitization when applied before a noxious insult, they are much less effective at reversing established sensitization. Studies in animals and humans demonstrate that temporary sensory blockade does not "reset" central changes once they are established. Researchers liken this to turning off the internet to fix corrupted software: when the connection returns, the corrupted program is still running. Similarly, drugs that briefly interrupt incoming pain signals cannot, by themselves, reverse long-standing neuroplastic changes in spinal and brain circuits.

Moreover, no pharmacological agent directly resolves the psychosocial and emotional drivers of chronic psychophysiologic pain. Medications do not renegotiate a caregiver's impossible role conflict, process a patient's ungrieved losses, or allow a person to express anger they have been suppressing for decades. They do not teach someone to set a boundary, to rest without guilt, or to recognize that "I have no choice" is an inner rule, not an external fact. At best, they make it somewhat easier to attempt these changes; at worst, they numb the distress enough that the underlying conflicts remain unaddressed and continue to fuel sensitization.

From a Pain Resolution Therapy perspective, the limits of pharmacology are not a failure of medicine; they are a reflection of category error. Drugs act primarily on bottom-up signaling and receptor-level modulation. Chronic psychophysiologic pain is maintained primarily by top-down prediction and learned associations embedded in the nervous system. It is, in essence, a learning disorder of threat detection. The system has learned, through experience, that certain movements, contexts, and emotional states are dangerous, and it protects the body with pain. No drug currently available can by itself teach the system that these predictions are wrong.

Pain Resolution Therapy does not reject medications outright. For some patients, particularly those with severe pain flares, comorbid inflammatory conditions, or acute exacerbations, judicious pharmacologic support can be compassionate and appropriate. Antidepressants with analgesic properties may support mood, sleep, and descending inhibition in ways that complement neuroplasticity-based work. But PRT regards medications as optional supports, not primary solutions. The core task is to change the nervous system's predictions and responses through experience: reattribution of pain from damage to protection, emotional processing of previously suppressed feelings, and resolution of inner conflicts that keep the system in a state of perpetual alarm.

Reattribution helps patients understand that their pain, especially when imaging is unremarkable and patterns are inconsistent with peripheral pathology, reflects a sensitized protective system rather than ongoing injury. This cognitive shift reduces fear and catastrophizing, both potent drivers of central sensitization. Emotional processing addresses unintegrated experiences—trauma, grief, shame, anger—that maintain autonomic arousal and somatic expression. Conflict resolution targets the Inner Conflict Circuit, helping patients move from "I have no choice" to workable, chosen positions in their roles and relationships. Behavioral experiments then provide the nervous system with concrete evidence that feared movements, expressions, or choices are in fact safe. Over time, this body of evidence allows the system to unlearn pain.

When viewed through this lens, the limitations of pharmacology become clear. Medications can sometimes lower the volume of the alarm signal temporarily. They cannot, on their own, convince the alarm system that the house is no longer on fire. Treating chronic neuroplastic pain with drugs alone is like treating a phobia with numbing cream on the skin: it may make certain sensations less sharp, but it does not change what the feared object means to the brain. For a disorder rooted in learning and meaning, the essential treatments must operate in that same domain.

For therapists and prescribers, this understanding invites a shift in conversation. Rather than promising that "the right medication" will fix the pain, clinicians can frame drugs as one small tool among many, useful primarily for reducing distress enough that patients can engage fully in the deeper work. They can also use the limited average benefit of medications and the reality of opioid-induced hyperalgesia and tolerance as honest grounding for discussing neuroplastic approaches. The message is not that patients should suffer without pharmacologic help, but that the path to enduring relief runs through nervous system retraining—through experiences that teach the brain and body that threat has passed—rather than through chemistry alone.

Why Psychoanalysis Fails to Resolve Chronic Pain

Psychoanalysis: The Missing Action Component

Why insight alone often doesn't retrain a sensitized nervous system.

0:00—

For more than a century, psychoanalytic thinking has shaped how clinicians understand the relationship between mind and body. Concepts like repression, conversion, and unconscious conflict have offered powerful metaphors for understanding medically unexplained symptoms, including chronic pain. It is therefore natural that, when confronted with persistent pain that defies biomedical explanation, many clinicians and patients look toward psychoanalysis or broadly psychodynamic therapies as a potential solution. The idea is appealing: if buried conflicts and unprocessed emotions are driving pain, then bringing these into awareness and insight should, in principle, relieve symptoms.

Yet when we examine the empirical record, a different picture emerges. Despite its rich theoretical contribution, classical psychoanalysis has not translated into a robust, evidence-based treatment for chronic pain. Systematic reviews note that research on psychoanalytic and traditional psychodynamic interventions in chronic musculoskeletal pain is sparse, composed mainly of case reports and uncontrolled series, with only a handful of controlled studies and no strong data showing superiority over active, time-limited, structured treatments. In contrast, guidelines and evidence reviews for chronic primary pain consistently identify other psychological approaches as first-line options, while psychoanalysis is either absent or mentioned only as experimental, costly, and poorly studied.

The question, then, is not whether psychoanalytic theory has anything meaningful to say about pain. It clearly does, especially regarding the role of trauma, attachment, and symbolic meaning. The question is why, in practice, psychoanalysis has failed to become an effective, scalable treatment for chronic pain, and what this tells us about what chronic pain actually requires from therapy. Pain Resolution Therapy takes these questions seriously. It does not reject psychoanalytic insights wholesale. Rather, it examines where the classical model is structurally mismatched with pain mechanisms and clinical realities, and it builds an alternative that retains depth while adding what psychoanalysis has historically lacked: a direct, structured focus on nervous system retraining and behavioral change.

When we speak of “psychoanalysis” in this context, it is important to distinguish between classical, long-term, high-frequency analysis and the broader family of psychodynamic therapies. The classical model typically involves several sessions per week, conducted over years, with the patient on the couch, free associating, and the analyst offering interpretations aimed at making the unconscious conscious. The focus is on insight into early relationships, internal object relations, and symbolic meanings of symptoms. Therapist neutrality, abstinence, and a relatively non-directive stance are central values. More contemporary psychodynamic approaches have modified this stance, becoming more relational, trauma-informed, or time-limited, but many still share the core assumption that change emerges primarily from insight and relational exploration.

In chronic pain, this assumption collides with neurobiology. Persistent pain in the absence of ongoing tissue damage is now understood as a disorder of central processing, characterized by central sensitization, altered descending modulation, and maladaptive predictive coding. Neural networks that detect threat and generate protective responses have undergone neuroplastic changes; they have learned pain. These changes are driven not only by early experiences but by repeated pairings of sensations, behaviors, and beliefs in adult life. The nervous system has developed highly practiced patterns: tightening in specific muscle groups when duty or guilt is activated, amplifying sensations when certain movements or contexts are anticipated, generating spikes of pain when internal conflicts reach a certain threshold. These are not simply symbols awaiting interpretation; they are conditioned responses embedded in circuits that need to be actively retrained.

Classical psychoanalysis does not systematically provide this retraining. Its core method—free association and interpretive exploration of unconscious meanings—relies heavily on verbal insight and reflective understanding. The patient becomes more aware of the childhood roots of their current patterns, of the ways they repeat early relational scenarios in the transference, and of the symbolic meanings of their symptoms. There is, to be sure, some implicit behavioral change: making different choices in relationships, tolerating new emotional experiences, altering one’s self-concept. But these changes are usually not targeted or tested in a structured fashion. The analyst does not typically design graded experiments to challenge pain-fear associations, instruct the patient in nervous system awareness or regulation, or explicitly work with somatic prediction and central sensitization.

The empirical literature reflects this mismatch. A review of psychotherapeutic approaches for chronic musculoskeletal pain notes that psychoanalytic treatments have been discussed conceptually in only a limited way by classical authors, and that empirical evaluation has lagged far behind other modalities. Where cognitive-behavioral therapy and mindfulness-based approaches have been subjected to multiple randomized controlled trials with measurable effects on pain intensity, disability, and mood, psychoanalytic approaches are represented mainly by two controlled studies in chronic musculoskeletal pain, plus heterogeneous case reports and small series. These controlled trials suggest that long-term psychoanalytic therapy may perform better than wait-list or basic drug therapy in some outcomes, but direct comparisons with other active psychological treatments are lacking, and pain-related outcomes are often secondary to broader psychological measures.

An evidence review for psychological therapies in chronic primary pain conducted for contemporary guideline development reaches a similar conclusion. It finds moderate-quality evidence supporting small to moderate benefits from structured, time-limited interventions like CBT, acceptance- and mindfulness-based treatments, and certain emotion-focused protocols. In contrast, there is insufficient high-quality evidence to recommend psychoanalysis as a first-line intervention. Veterans’ health systems and other large bodies that issue practice recommendations identify CBT, ACT, and mindfulness-based stress reduction as “evidence-based psychotherapies for chronic pain,” with no comparable endorsement of psychoanalysis. This absence is not ideological; it reflects decades of differential research investment and outcome.

One major reason for this gap is methodological. Classical psychoanalysis is difficult to study in randomized, controlled formats. Its lengthy duration, individual tailoring, and resistance to manualization make it challenging to define dosage, standardize interventions, or recruit sufficient samples with adequate controls. But methodological difficulty alone cannot explain the lack of evidence. When psychodynamic procedures have been modified to be briefer, more structured, and more hybridized with behavioral elements, they become more amenable to evaluation—and, notably, their effectiveness improves in domains closer to what chronic pain requires.

Intensive short-term dynamic psychotherapy, for example, is a highly active, emotion-focused, time-limited form of psychodynamic therapy. Meta-analytic data suggest that intensive short-term dynamic psychotherapy can produce large within-group effects on pain, depression, and anxiety in somatic symptom and chronic pain populations, and in some trials, outperform cognitive-behavioral comparators on pain and mood measures. Similarly, psychodynamic interpersonal therapy, another structured, relationally focused modality, appears feasible and acceptable in case series of chronic low back pain and may reduce depression and interpersonal problems, though pain distress remained relatively stable. These findings are preliminary and far from conclusive, but they are instructive: as psychodynamic methods become more experiential, more active, and more structured, their alignment with pain mechanisms—and their impact—improves.

This underlines a central critique. The problem is not that attending to unconscious meaning, early trauma, or attachment is irrelevant for chronic pain. The problem is that a purely insight-oriented, interpretive stance, delivered over years with minimal attention to specific nervous system processes, does not match what psychophysiologic pain needs in practice. Chronic pain patients do not simply require understanding; they require new experiences that directly contradict their nervous system’s predictions and learned associations. They need to feel their bodies in new ways, to move differently under conditions of safety, to express previously suppressed emotions while tracking somatic shifts, to make and test new choices in relationships and roles that have been held as inescapable. This is not the core business of classical psychoanalysis.

A second limitation of traditional psychoanalysis in chronic pain is its passivity with respect to action. The analytic frame typically emphasizes neutrality, non-directiveness, and a focus on transference rather than on coaching specific changes outside the consulting room. There is deep value in this stance for many conditions, especially where the main problem is intrapsychic conflict or relational patterns that unfold within the therapeutic relationship itself. But in chronic pain driven by central sensitization and a sensitized prediction system, waiting passively for change to emerge from insight is often too slow, too uncertain, and insufficiently targeted.

Central sensitization, by definition, involves heightened responsiveness of the central nervous system to both noxious and non-noxious input. The volume knob is turned up at the spinal dorsal horn, in ascending pathways, and in cortical networks integrating threat, emotion, and sensation. Descending modulatory systems that could dampen this signal are biased toward facilitation rather than inhibition. These changes are plastic, but they are maintained by ongoing patterns of attention, interpretation, emotion, and behavior. To reverse them, patients must repeatedly experience that what their system predicts—danger, damage, catastrophe—does not in fact occur when they move, feel, or choose differently. This typically requires explicit behavioral experiments, graded exposure, and somatic tracking that ties cognitive shifts directly to bodily experience. An analyst who offers only interpretations without helping the patient design and enact such experiments leaves the nervous system’s procedural learning largely untouched.

Third, the sheer duration and cost of classical psychoanalysis are misaligned with the realities of chronic pain care. Many patients with persistent pain have already spent years navigating the healthcare system, undergoing tests, procedures, and consultations that have drained their time, finances, and hope. They often arrive at psychological treatment after multiple disappointments and with limited resources. A therapy model that assumes several sessions per week for years is out of reach for most and difficult to justify from a public health perspective, particularly in the absence of strong evidence for pain resolution. Health systems that must allocate finite resources naturally favor interventions with demonstrable benefit in shorter time frames. This is one reason why guideline panels and payers endorse briefer, protocolized treatments over open-ended analysis.

Moreover, long duration does not guarantee deeper or more durable change in pain mechanisms. When psychodynamic approaches are compressed and focused—limited sessions, clear targets, active engagement—they often achieve larger shifts in somatic symptoms than extended, less structured work. This suggests that it is not “more analysis” that chronic pain needs; it is the right kind of experiential learning in the right dose, organized around the real drivers of central sensitization and predictive threat.

Fourth, and perhaps most crucially, classical psychoanalysis largely lacks a direct language for nervous system retraining. It speaks fluently about meaning, symbolism, defenses, and internal objects. It says relatively little, in concrete terms, about nociceptive processing, central sensitization, descending modulation, interoception, or predictive coding. Some contemporary analytic writers have begun integrating neuroscience and pain science into psychodynamic formulations, framing chronic pain as a form of dissociative fragmentation of the embodied self or as an expression of unintegrated traumatic memory networks. These theoretical integrations are intellectually rich. But as long as they are not translated into specific, replicable interventions that systematically alter how the nervous system processes threat and sensation, they remain conceptual rather than therapeutic advances.

Pain Resolution Therapy takes a different stance. It recognizes that many chronic pain patients do, in fact, carry histories of trauma, attachment disruption, and deep inner conflict. It acknowledges that symptoms can function symbolically, that roles and identities shape how the nervous system responds to demand and emotion, and that unconscious processes are involved. But it refuses to stop at insight. It insists that the nervous system must be explicitly engaged and retrained at the level where pain is constructed.

Where a classical analytic formulation might say, “Your pain represents the unspoken anger toward your father that you turned against yourself,” Pain Resolution Therapy asks, “What happens in your body, right now, when you allow yourself to feel even a small amount of that anger and stay with the physical sensations?” It then works with the answer, not only interpretively but experientially. It helps the patient notice, for instance, that their back tightens when guilt arises, that their jaw clamps when they imagine saying no, that their pain spikes when they silently comply with an internal “must” against their own limits. It formulates these patterns as elements of the Inner Conflict Circuit and uses that formulation to design specific experiments in feeling and behavior.

Where classical psychoanalysis might explore at length the historical roots of a patient’s inability to rest, Pain Resolution Therapy, once a safe conceptual and relational frame is established, will ask the patient to rest in a small, concrete way and track what happens—not only in life but in pain. It will ask them to say no once, feel the guilt that arises, and observe whether the feared catastrophe actually occurs. It will invite them to bring attention to a flare, map the conflict that coincided with it, and treat the flare as an intelligible reaction of a sensitive system rather than as a random punishment. In each of these steps, the nervous system is given new data that contradict its predictions, and neuroplastic changes can begin.

This is the “missing action component” in psychoanalysis when applied to chronic pain. Without structured opportunities to behave, feel, and inhabit roles differently—and to see pain respond—insight remains largely intellectual. The patient may understand, at a narrative level, why they are in pain, but their body has not had sufficient new experience to stop generating it. They can tell a coherent story about trauma, conflict, and symbolism, yet still find that their pain returns in full force whenever the old conditions arise. This gap between understanding and transformation is precisely what a neuroplasticity-informed method like Pain Resolution Therapy is designed to bridge.

It is important to be fair in this critique. Psychoanalysis has contributed foundational ideas about how psychological factors shape somatic experience. Its emphasis on depth, complexity, and the importance of the therapeutic relationship has influenced many of the more effective, time-limited therapies now supported by evidence. Short-term dynamic and interpersonal psychotherapies that show promise in chronic pain are, in many ways, psychoanalysis made more practical: they retain an interest in affect, attachment, and meaning while adopting structured, active, dose-limited formats. The point, then, is not to dismiss psychoanalysis but to recognize that, in its traditional form, it is not configured for the specific task of resolving chronic psychophysiologic pain.

For clinicians, the implications are clear. Chronic pain demands approaches that do more than illuminate unconscious dynamics. It requires methods that directly target central sensitization and predictive threat through carefully designed experiences. Treatments must be sufficiently structured to be studied, sufficiently brief to be accessible, and sufficiently embodied to speak the nervous system’s language. Insight is valuable when it opens the door to new choices and new experiences. It is insufficient when it remains a story told about pain that pain does not heed.

Pain Resolution Therapy grows out of this recognition. It integrates what is most clinically useful from depth psychology—the attention to conflict, trauma, identity, and relational patterns—with contemporary pain neuroscience and an insistence on active, testable change. It treats chronic pain not as a mysterious conversion of psychic conflict into somatic symptoms, but as a learned, maintainable state of neural overprotection that can be unlearned when conflicts are brought into the open, emotions are allowed to move through the body, and behavior is adjusted in line with genuine values rather than inherited dictates. In doing so, it offers a way to honor the complexity that psychoanalysis was right to emphasize while correcting the passivity, inefficiency, and evidentiary weaknesses that have prevented psychoanalysis from resolving chronic pain reliably.

Methodology

How Your Nervous System Creates Pain Without Tissue Damage

Central Sensitization

Why pain persists long after tissue has healed — and how the nervous system learns to produce it.

0:00—

For most of human history, pain has been understood through a simple and intuitive model. Tissue gets damaged, nerve endings detect that damage, signals travel to the brain, and the brain registers pain proportional to the extent of injury. This model works remarkably well for acute pain following trauma. When you break a bone or burn your hand on a hot stove, there is a clear relationship between tissue damage and pain intensity. The pain serves an obvious protective function, compelling you to remove yourself from danger and protect the injured area during healing. However, this straightforward damage-equals-pain model breaks down completely when applied to chronic pain. Millions of people experience severe, persistent pain with minimal or no identifiable tissue pathology. They undergo extensive imaging studies that reveal normal structures or minor degenerative changes insufficient to explain their symptoms. They are told their tests are normal, yet their pain is devastatingly real. This disconnect between tissue state and pain experience has frustrated both patients and clinicians for decades. The explanation lies in a phenomenon that fundamentally challenges our intuitive understanding of pain. It is called central sensitization.

Central sensitization represents one of the most important discoveries in pain neuroscience over the past three decades. It is defined by the International Association for the Study of Pain as an increased responsiveness of nociceptive neurons in the central nervous system to their normal or subthreshold afferent input. This technical definition describes something profound. The central nervous system, comprised of the brain and spinal cord, can undergo changes that amplify pain signals independent of what is happening in the peripheral tissues. Once central sensitization is established, pain is no longer simply a signal reflecting tissue damage. It becomes a product of the nervous system itself, generated and maintained by changes in how the system processes sensory information. Pain persists not because tissue remains damaged but because the nervous system has learned to produce pain. It has become hypersensitive, hyperreactive, and stuck in a state of alarm that far outlasts any protective purpose.

To understand how central sensitization develops, we must first understand normal pain processing. Under typical circumstances, specialized nerve endings called nociceptors detect potentially harmful stimuli such as mechanical pressure, extreme temperatures, or chemical irritants. These nociceptors transmit signals via unmyelinated C-fibers and thinly myelinated A-delta fibers to the dorsal horn of the spinal cord. At this first synaptic relay, neurotransmitters including glutamate, substance P, and calcitonin gene-related peptide are released from the presynaptic terminals of these primary afferent neurons. These chemical messengers bind to receptors on second-order neurons in the spinal cord, which then transmit signals upward through the brainstem to various regions of the brain including the thalamus, somatosensory cortex, anterior cingulate cortex, and insula. The brain integrates these signals with contextual information, memories, emotions, and expectations to construct the experience we call pain. In acute pain, this entire system functions adaptively. The intensity of pain roughly corresponds to the degree of tissue threat, and pain resolves as tissue heals.

Central sensitization disrupts this orderly process through a cascade of neuroplastic changes. Neuroplasticity, the nervous system's capacity to modify its structure and function in response to experience, is typically adaptive. It allows us to learn, to recover from injury, and to adjust to changing environments. However, the same mechanisms that enable beneficial learning can also produce pathological changes. When nociceptive input is sustained, intense, or repeated, as occurs during prolonged injury, inflammation, or repeated exposure to painful stimuli, the nervous system undergoes activity-dependent modifications. Synaptic connections strengthen. Neuronal excitability increases. Inhibitory mechanisms weaken. These changes, initially reversible and potentially protective, can become self-sustaining. The result is a nervous system that amplifies pain signals, responds to normally innocuous stimuli as if they were harmful, and maintains pain long after the original cause has resolved.

The molecular mechanisms underlying central sensitization have been extensively characterized in laboratory models. A critical component involves the NMDA receptor, a specific type of glutamate receptor that plays a pivotal role in synaptic plasticity. Under normal circumstances, NMDA receptors are blocked by magnesium ions that prevent calcium from entering the postsynaptic neuron. Sustained or repeated release of glutamate and substance P from nociceptor terminals causes sufficient depolarization of the postsynaptic membrane to expel the magnesium block from the NMDA receptor channel. Once unblocked, calcium floods into the neuron, activating intracellular signaling cascades that enhance synaptic transmission. Protein kinases are activated. Gene transcription is altered. New receptors are inserted into the membrane. The neuron becomes more excitable and more responsive to subsequent inputs. This process, described as long-term potentiation when it occurs in learning and memory circuits, becomes maladaptive when it occurs persistently in pain pathways.

One of the hallmark features of central sensitization is wind-up, also called temporal summation. Wind-up refers to a progressive increase in the firing frequency and magnitude of dorsal horn neurons in response to repeated C-fiber stimulation at frequencies typically above 0.33 hertz. When noxious stimuli are applied repetitively, rather than producing a stable pain response, each subsequent stimulus produces greater pain than the one before. Healthy individuals show some degree of temporal summation, but in people with central sensitization, this phenomenon is dramatically exaggerated. A series of identical moderately painful heat pulses or pressure stimuli that should produce consistent ratings instead generates escalating pain, with the final stimulus feeling far more intense than the first despite being physically identical. This temporal summation is NMDA receptor-dependent and reflects the enhanced excitability of central pain pathways. It demonstrates that pain intensity is not determined solely by peripheral input but is actively constructed by the state of the nervous system.

Central sensitization also produces spatial expansion of pain sensitivity. Normally, pain is localized to the site of injury or stimulation. After central sensitization develops, the receptive fields of dorsal horn neurons expand. Neurons that previously responded only to stimulation of a small, defined body region now respond to stimulation of much larger areas, including regions far from the original injury. This phenomenon, termed secondary hyperalgesia, explains why people with chronic pain often experience spreading pain that extends well beyond the initially painful area. A person with chronic low back pain may develop pain in the buttocks, thighs, and legs despite no structural pathology in those regions. Someone with a shoulder injury may develop pain in the neck, arm, and hand. This spread occurs not through progression of tissue damage but through changes in central nervous system processing that expand the territory perceived as painful.

Another critical feature of central sensitization is allodynia, the perception of pain in response to stimuli that normally do not cause pain. Light touch, gentle pressure, or mild temperature changes that healthy individuals experience as innocuous become painful for those with central sensitization. This occurs because the altered state of central neurons lowers the activation threshold, causing them to fire action potentials in response to inputs from low-threshold mechanoreceptors and thermoreceptors that normally signal only touch or temperature. Wide-dynamic-range neurons in the dorsal horn, which under normal conditions respond to both innocuous and noxious stimuli but distinguish between them, lose this discrimination capacity. Everything feels potentially threatening. The nervous system interprets benign sensory information as danger signals. Patients report that clothing feels painful against their skin, that gentle massage aggravates their symptoms, or that even the weight of bed sheets becomes intolerable. These experiences are not imagined or exaggerated. They reflect genuine changes in sensory processing at the level of the spinal cord and brain.

Hyperalgesia, an exaggerated pain response to noxious stimuli, accompanies allodynia in central sensitization. A stimulus that should produce mild discomfort instead generates severe pain. The input-output relationship between stimulus intensity and pain perception becomes distorted, with the gain turned up throughout the system. This amplification means that daily activities involving normal loading of tissues can produce disproportionate pain responses. Walking, bending, reaching, or maintaining postures that involve some degree of mechanical stress on tissues elicit pain that far exceeds what would be expected based on the actual tissue loading. Imaging studies may reveal minimal structural abnormalities, yet the person experiences debilitating pain. The disconnect between tissue pathology and pain intensity, once interpreted as evidence of psychological problems or malingering, is now understood as the signature of central sensitization.

Descending pain modulation systems play a crucial role in either protecting against or promoting central sensitization. The brain does not passively receive pain signals. It actively modulates incoming nociceptive information through descending pathways that can either inhibit or facilitate pain transmission at the spinal level. Descending inhibitory pathways originate primarily in the periaqueductal gray and rostral ventromedial medulla, utilizing serotonergic and noradrenergic neurotransmitters to suppress dorsal horn neuron excitability. This endogenous analgesic system normally serves to dampen pain signals during situations requiring focused attention despite injury, such as in combat or intense competition. However, in chronic pain conditions, this protective descending inhibition often becomes dysfunctional. Multiple studies have demonstrated that patients with fibromyalgia, irritable bowel syndrome, temporomandibular disorder, and other chronic primary pain conditions show impaired conditioned pain modulation, the human correlate of descending pain inhibition. Rather than pain inhibiting pain through activation of these descending controls, pain begets more pain. Simultaneously, descending facilitatory pathways from the rostral ventromedial medulla and anterior cingulate cortex become hyperactive, further amplifying ascending pain signals. The balance shifts dramatically toward facilitation and away from inhibition, creating a state where the nervous system not only fails to suppress pain but actively enhances it.

Structural brain imaging studies have revealed that chronic pain is associated with measurable changes in brain anatomy. Meta-analyses synthesizing data from numerous studies have found alterations in gray matter volume, cortical thickness, and white matter integrity in regions comprising pain processing networks. The anterior cingulate cortex, insula, dorsolateral prefrontal cortex, thalamus, and hippocampus show structural reductions in patients with chronic pain compared to healthy controls. These changes were initially interpreted as evidence that chronic pain causes brain damage, reinforcing a narrative of pain as a progressive neurodegenerative disease. However, more nuanced understanding has emerged. At least some of these structural changes appear to be reversible consequences of chronic nociceptive transmission rather than irreversible damage. Studies of patients with hip osteoarthritis demonstrated that gray matter reductions normalized after successful treatment with hip replacement surgery, suggesting that structural brain changes can reflect the presence of ongoing pain rather than permanent injury. The extent and pattern of structural alterations may relate to pain duration, severity, and the specific somatotopic representation involved, reflecting the brain's dynamic response to chronic nociceptive states.

Functional brain imaging reveals altered patterns of connectivity in chronic pain. Resting-state functional MRI studies demonstrate that individuals with chronic pain show disrupted connectivity within and between brain networks including the default mode network, salience network, and sensorimotor network. During sustained pain in healthy volunteers, primary sensorimotor cortex connectivity shifts away from sensorimotor networks and toward salience networks, which prioritize detection of salient stimuli requiring attention. In chronic pain patients, these connectivity changes persist even at rest, suggesting that the brain remains in a sustained state of altered network organization. Connectivity between regions involved in pain processing and regions involved in emotional regulation, threat detection, and cognitive control is consistently altered. These functional changes likely contribute to the multidimensional nature of chronic pain experience, where pain is not simply a sensory event but becomes intertwined with attention, emotion, catastrophizing, and disrupted cognitive function.

The concept of nociplastic pain, introduced by the International Association for the Study of Pain in 2017, recognizes central sensitization as a distinct pain mechanism. Nociplastic pain is defined as pain that arises from altered nociception despite no clear evidence of actual or threatened tissue damage causing activation of peripheral nociceptors, or evidence for disease or lesion of the somatosensory system causing the pain. This definition differentiates it from nociceptive pain, where tissue damage directly drives pain, and neuropathic pain, where disease or lesion of the somatosensory system is present. Nociplastic pain describes a state where pain processing itself has become pathological, where sensitivity is heightened not because tissues are damaged or nerves are injured but because the nociceptive system's function has been altered. Conditions such as fibromyalgia, chronic widespread pain, many cases of chronic low back pain, tension-type headache, irritable bowel syndrome, and other functional pain syndromes are now recognized as manifestations of nociplastic pain driven by central sensitization.

Clinically, central sensitization manifests in patterns that distinguish it from peripheral nociceptive pain. Pain is often disproportionate to the degree of tissue pathology found on examination or imaging. It spreads beyond the original site of injury in non-anatomical patterns. It persists long after tissue healing should have occurred, continuing months or years after the initiating event. Multiple symptoms often coexist, including not only pain but fatigue, cognitive difficulties, sleep disturbance, and mood changes, reflecting the widespread nature of nervous system dysregulation. Pain is highly variable, fluctuating in intensity based on stress, activity, sleep quality, and emotional state rather than following predictable patterns based on mechanical loading or tissue use. Stimuli that should not be painful, such as light touch or gentle movement, provoke pain responses. These clinical features form a constellation that, while not definitively diagnostic of central sensitization in the absence of direct measurement, strongly suggests that pain is maintained by central nervous system mechanisms rather than ongoing peripheral pathology.

The recognition of central sensitization as a primary driver of chronic pain has profound implications for treatment. If pain is generated and maintained by neuroplastic changes in the central nervous system rather than by ongoing tissue damage, then interventions targeting peripheral structures are unlikely to provide lasting relief. Surgery to remove herniated discs, joint replacements to eliminate osteoarthritic joints, or nerve blocks to interrupt peripheral signals may fail to resolve pain if the central amplification mechanisms remain unchanged. This explains high rates of failed back surgery syndrome, where patients undergo technically successful operations that correct structural abnormalities yet continue experiencing severe pain. It explains why opioid medications, which act primarily to suppress nociceptive transmission, show limited long-term efficacy for chronic pain. It explains why physical therapy focused exclusively on biomechanical correction often produces only temporary improvements. These approaches miss the target.

Effective treatment of pain driven by central sensitization requires interventions that address neuroplasticity itself. Just as the nervous system learned to amplify pain signals through repeated experience with threat and injury, it can potentially learn to normalize its responses through new experiences that promote safety and recalibration. Pain Resolution Therapy is built on this understanding. It recognizes that central sensitization is not a permanent structural change but a learned state maintained by ongoing signals of threat, unresolved emotional conflicts, and ingrained protective patterns. The framework addresses three primary mechanisms simultaneously. First, it teaches reattribution of pain from tissue damage to brain-generated signals, helping patients recognize that their pain reflects nervous system dysfunction rather than ongoing injury. Second, it systematically processes suppressed emotions and unresolved trauma that maintain autonomic arousal and threat detection. Third, it identifies and resolves internal conflicts related to roles, boundaries, and unexpressed needs that keep the nervous system locked in protective overdrive.

This integrated approach targets the mechanisms maintaining central sensitization at multiple levels. Reattribution work reduces fear and catastrophizing, which directly influences descending pain modulation systems. When patients understand that pain signals nervous system overprotection rather than tissue damage, they can approach feared activities and sensations without triggering amplification. Emotional processing addresses the autonomic arousal and limbic activation that bias descending systems toward facilitation. Suppressed anger, unprocessed grief, chronic fear, and other avoided emotions create sustained activation in emotion-regulatory circuits that overlap extensively with pain modulation pathways. When these emotions are acknowledged, expressed, and integrated, the nervous system's baseline threat level decreases. Conflict resolution removes the ongoing triggers that maintain protective vigilance. When individuals resolve the role conflicts, boundary violations, and unmet needs that their pain has been signaling, the nervous system no longer requires pain as a warning system.

Research demonstrates that interventions targeting these brain-based mechanisms can produce outcomes far exceeding traditional pain management. Studies examining approaches that combine pain reattribution, emotional awareness and expression, and behavioral experiments to test safety show that approximately two-thirds of participants achieve pain-free or nearly pain-free status after treatment, compared to 20 percent with placebo interventions. The mechanism involves neuroplastic change in the opposite direction from sensitization. As threat perception decreases, descending inhibition strengthens and descending facilitation weakens. As patients accumulate experiences of safety during previously avoided activities, temporal summation normalizes. As emotional processing reduces limbic hyperactivity, the spatial expansion of pain sensitivity reverses. The nervous system learns that it can turn down the volume, that amplification is no longer necessary, and that normal sensory processing can resume.

Central sensitization is not a speculative construct or a metaphor. It is a well-characterized neurobiological phenomenon with identified molecular mechanisms, demonstrable changes in neuronal function, and measurable alterations in brain structure and connectivity. It explains why pain can persist without tissue damage, why pain intensity often bears little relationship to structural pathology, why pain spreads beyond injury sites, and why treatments targeting peripheral tissues often fail. Recognizing central sensitization transforms how we understand chronic pain, shifting the focus from damaged body parts to a dysregulated nervous system, from permanent structural problems to potentially reversible functional changes, and from management of symptoms to resolution of underlying mechanisms. For the millions experiencing chronic pain that has defied conventional treatment, understanding central sensitization offers both explanation and hope. Pain generated by the brain through neuroplastic processes can potentially be reversed through targeted interventions that harness neuroplasticity in the opposite direction, teaching the nervous system that it is safe to turn down the volume, to stop amplifying signals, and to return to normal processing. Pain Resolution Therapy provides the framework for achieving this reversal by addressing the emotional, cognitive, and behavioral patterns that maintain the sensitized state. Pain becomes not an inevitable consequence of aging or permanent injury but a learned state that can be unlearned through systematic intervention targeting the actual mechanisms at work.

A New Model for Understanding Psychophysiologic Pain

Inner Conflict Circuit

How chronic internal dilemmas sustain autonomic threat and central sensitization.

0:00—

When clinicians speak about the role of psychology in chronic pain, the language is often vague. Patients are told that “stress makes pain worse,” that they are “holding tension,” or that their pain is “probably related to emotions.” While there is a kernel of truth in these statements, their imprecision is clinically unhelpful and often experienced by patients as invalidating. They reduce a complex neurobiological process to a slogan. They do not explain which aspects of a person’s inner life are relevant, how exactly those processes affect the nervous system, or why pain might continue long after an injury has healed. Pain Resolution Therapy introduces a more precise and clinically usable framework: the Inner Conflict Circuit.

The Inner Conflict Circuit refers to a specific pattern of chronic internal conflict that keeps the nervous system in a sustained state of threat, thereby maintaining central sensitization and psychophysiologic pain. Rather than treating “stress” as a homogeneous construct, this model focuses on the particular dilemmas that patients live inside every day: the pull between duty and rest, between authenticity and approval, between anger and peace-keeping, between self-protection and loyalty. These are not abstract philosophical tensions. They show up in very concrete questions: Do I go to my mother again tonight even though my back is burning and I feel resentful, or do I stay home and drown in guilt? Do I say what I actually think in this meeting and risk conflict, or do I stay silent and feel my jaw lock and my stomach knot? Do I set a boundary with my partner about their drinking, or do I keep tolerating it while my chest feels tighter each week?

From a Pain Resolution Therapy perspective, chronic pain in many patients is not simply a reaction to external stressors. It is the bodily expression of conflicts that have no obvious resolution within the person’s current map of the world. When every available option feels threatening, the nervous system has no safe path to stand down. Instead, it stays on continuous alert. Sympathetic activation remains high, parasympathetic recovery remains limited, and the systems that would normally buffer and resolve stress never get a full opportunity to do so. Over months and years, this unresolved, internally generated threat state acts on the same neural circuitry involved in pain modulation and central sensitization.

To understand how the Inner Conflict Circuit functions, it is helpful to consider the nervous system’s basic architecture. The brain continually evaluates incoming signals for threat or safety. This evaluation is not purely conscious. Structures such as the amygdala, anterior insula, and dorsal anterior cingulate cortex scan for cues of danger, discrepancy, and loss of control. When threat is detected, the hypothalamus, brainstem, and autonomic nervous system coordinate a response: heart rate increases, muscles tense, attention narrows, and stress hormones are released. In acute danger, this system is protective. It mobilizes the organism to fight, flee, or freeze. Once the threat passes and a clear resolution is achieved, the system can reset.

Chronic internal conflicts are different. There is no discrete external event that can be escaped or defeated. The “threat” resides in anticipated emotional consequences and relational meanings. Saying “no” to a parent may be experienced, at a deep level, as risking abandonment, betrayal of identity, or violation of a moral code. Continuing to say “yes” may be experienced as risking breakdown, self-betrayal, or loss of integrity. Both branches of the dilemma carry significant emotional cost. The nervous system cannot find a choice that feels fully safe. The result is a chronic approach–avoidance configuration: powerful drives pull in opposite directions, and neither can be enacted without triggering another alarm.

In such contexts, cognitive statements like “I have no choice” or “I have to” are markers, not metaphors. They indicate that the person’s internal model of their life contains only high-threat options. When someone says, “I have to go to work even if I cannot stand the pain,” or “I can’t say no to my sister; she would fall apart,” they are not being dramatic. They are reporting a genuine perception of constraint. The Inner Conflict Circuit conceptualizes these statements as signs that specific neural circuits linking role expectations, attachment needs, and threat detection have become locked into rigid patterns. Fear, loyalty, and guilt are running strongly and simultaneously. The person is held in a state where every imagined action implicates deeply held values and fears.

Neurobiologically, this has several consequences. First, chronic internal conflict maintains prolonged activation of limbic structures, particularly the amygdala and related salience networks, which in turn bias the entire system toward detecting danger rather than safety. The amygdala’s increased baseline activity heightens responses to ambiguous cues and bodily sensations, making innocuous interoceptive signals more likely to be interpreted as signs of threat. Second, prefrontal regions involved in evaluation, integration of competing values, and top-down inhibition of limbic responses are overloaded with unresolved dilemmas. Instead of briefly engaging to weigh options and then standing down, prefrontal circuits remain engaged in repetitive, circular problem-solving that never reaches a conclusion. Functional imaging studies of patients with chronic pain and high levels of worry and catastrophizing show precisely this pattern: persistent activation in anterior cingulate and prefrontal areas associated with “misdirected problem solving” in the context of pain.

Third, the autonomic nervous system and hypothalamic–pituitary–adrenal axis receive repeated signals that “something is wrong” but are never allowed to complete a full stress response cycle. The person does not flee the situation, does not assertively confront it, does not fully submit in a way that feels chosen; they oscillate inside. Each imagined action triggers anticipatory arousal, but no action is taken that convincingly resolves the threat. Over time, this leads to allostatic load: wear and tear on stress-regulation systems, increased baseline sympathetic tone, blunted parasympathetic recovery, and dysregulated cortisol rhythms. These, in turn, foster both peripheral and central sensitization, lowering thresholds in nociceptive pathways and amplifying pain signals.

Importantly, the Inner Conflict Circuit model differs from generic “stress causes pain” explanations in its specificity. Not all stressors are equal in their impact on pain. Time-limited demands with clear solutions—such as sitting an exam, meeting a deadline, or navigating a single difficult conversation—may temporarily increase symptoms, but they do not typically produce the complex, fluctuating pain patterns characteristic of psychophysiologic conditions. What seems particularly toxic for pain systems are chronic, value-laden conflicts in roles and relationships that implicate identity, morality, and attachment. Being the “good daughter” who must always show up, the “strong one” who must never show weakness, the “peacemaker” who must stop all conflict, the “provider” who must never rest—these role identities interact with specific life circumstances to create unsustainable internal demands.

For example, consider a middle-aged woman with chronic lumbar pain who works full-time, cares for two children, and provides extensive support to an aging parent. On one side of her conflict are deeply held values of duty, loyalty, and self-sacrifice learned in childhood. On the other side is her body’s need for rest, autonomy, and fairness. Each time she contemplates reducing her caregiving hours or asserting a boundary, intense guilt and fear of being “selfish” or “ungrateful” surface. Each time she forces herself to keep going, resentment and exhaustion rise. The Inner Conflict Circuit in this case can be described as “I must be endlessly available to others or I am a bad person” versus “If I keep doing that, I am going to collapse.” The nervous system detects no safe path, so it generates pain as a form of protest and protection. Pain justifies reducing activity without directly confronting the conflict. It also functions as a non-verbal communication that “this life is not sustainable,” when the person cannot yet say that explicitly.

This dynamic is not confined to caregiving roles. In occupational contexts, conflicts often emerge between authenticity and approval. A person may feel compelled to comply with workplace demands that violate their values or limits, fearing job loss, social rejection, or humiliation if they speak up. The nervous system registers both the external demands and the internal protest. Anger arises at being treated unfairly. Fear arises about the consequences of resisting. Shame arises at imagined failure. When these emotions cannot be acknowledged, negotiated, or acted upon, they are driven into bodily expression. Chronic shoulder, neck, or headache pain in such cases can be understood as the muscular and autonomic correlate of trying to hold incompatible positions at once: appearing agreeable while internally bracing against violation.

Anger-versus-peace-keeping conflicts are another frequent driver. Many patients with chronic pain report life histories in which open anger was either dangerous (because it provoked violence or abandonment) or morally condemned (because “good people do not get angry”). The nervous system therefore treats anger itself as a threat. When circumstances in adult life evoke legitimate anger—unfair workload, disrespect, exploitation—the person cannot safely express it. The anger is inhibited at the level of action and explicit awareness, but the associated physiological activation has nowhere to go. Sympathetic arousal, muscle tightening, and pain amplification become the default channels. The body “speaks” the anger through spasm, burning, or pressure, while the conscious mind insists that it is “not a big deal” or “not worth making a fuss about.”

The Inner Conflict Circuit framework is supported by a growing body of research showing that psychological processes such as catastrophizing, fear-avoidance, emotional suppression, and role strain are not mere reactions to pain but predictors of its onset and persistence. Longitudinal studies indicate that individuals who chronically suppress emotion or lack skills in emotional processing are more likely to develop centralized pain conditions, and their pain tends to interfere more with functioning. Experimental work demonstrates that suppressing anger in provocation tasks increases both subjective pain intensity and physiological arousal compared to conditions where anger can be expressed more freely. These findings align with the observation that chronic unresolved conflicts, rather than transient stressors, are particularly potent drivers of pain.

Within Pain Resolution Therapy, the Inner Conflict Circuit is not just a metaphor; it is the organizing map for intervention. The first task is to identify the person’s central conflict in their own language with at least one concrete scene where pain is present. Instead of conceptualizing the problem as “stress” or “overload,” the practitioner works with formulations like “I must keep everyone happy, even when I am exhausted, or I am a failure" versus "If I keep doing that, I am going to collapse," or "I must never show weakness" versus "Part of me desperately wants to rest and be cared for." This formulation is then linked explicitly to pain episodes: When does pain spike? During which interactions? After which decisions or non-decisions? How does pain behave on days when the conflict is especially active versus days when it is quieter?

Once the Inner Conflict Circuit is mapped, the therapeutic work moves beyond generic relaxation or coping strategies. The goal is to reduce the nervous system’s sense of being trapped between intolerable options. That involves bringing into awareness the emotional and relational rules that keep one side of the conflict rigidly in place (for example, “a good son never says no,” “if I rest, I am lazy,” “if I speak up, I will be left”). It involves helping the person feel, in tolerable doses, the anger, grief, guilt, and fear that have been carried in their body. And crucially, it involves designing behavioral experiments that test small, concrete shifts in how they live the conflict.

These experiments are not arbitrary. They are chosen to touch the heart of the dilemma while keeping risk manageable. For a person trapped in duty-versus-rest, an experiment may be to decline one non-essential request and observe what actually happens, both externally and internally. For someone whose conflict centers on authenticity versus approval, an experiment might be to express one honest opinion in a low-stakes setting and notice whether the feared catastrophe materializes. For a person struggling with anger versus peace-keeping, an experiment might involve stating one boundary calmly but firmly, then tracking both relational outcomes and the body’s response over several days.

From a nervous system perspective, these experiments create new prediction errors. The brain has been predicting that certain actions—saying no, resting, disagreeing—will lead to intolerable outcomes such as abandonment, moral collapse, or chaos. When the person engages in a carefully chosen action and discovers that the feared outcome either does not occur or is bearable, the prediction is disconfirmed. Over time, and with repetition, limbic threat responses weaken, prefrontal regulation strengthens, and descending inhibitory pathways can reassert themselves. Pain often decreases not because peripheral tissues have changed but because the underlying conflict has moved from an inescapable trap to a “workable position,” where the person can say, “This is the path I am choosing; I do not like all of the cost, but I can live with it.”

This “resolution point” in Pain Resolution Therapy is not a fantasy of a life without conflict or pain. It is a realistic stance in which the Inner Conflict Circuit is no longer firing continuously. The person has accepted that every real option will involve some emotional pain—guilt, grief, fear—but they have stopped insisting on a cost-free solution. They can name their choice and its emotional price. They can tolerate mixed feelings without oscillating endlessly. They act more consistently in line with their values rather than purely out of fear, guilt, or habit. In this state, the nervous system no longer perceives the conflict as an unsolvable, ongoing threat requiring constant high alert. Allostatic load can decrease. Central sensitization can begin to unwind.

Clinically, there are observable markers that the Inner Conflict Circuit is shifting. Language becomes clearer. Patients who once said “I have no choice” begin to say, “I think I need to…” or “I am leaning toward…” Inner argument decreases; there is less mental ping-pong and more settled, if not entirely comfortable, conviction. Emotional responses to key conflict scenes become more manageable—still poignant, but less overwhelming or destabilizing. Small behavioral changes—saying no once, resting openly, asking for help—are enacted and repeated. Pain often becomes more comprehensible to the patient; flares are recognized as linked to specific conflict activations rather than as random attacks. Even when symptom intensity does not immediately fall dramatically, suffering and disability can decrease because the person is no longer fighting themselves all day.

It is essential to differentiate this conflict-focused model from older psychosomatic theories that implied that certain personality traits or unconscious wishes “caused” specific symptoms in a deterministic manner. The Inner Conflict Circuit does not pathologize personality. It recognizes that people with chronic pain are often those who have tried hardest to live up to demanding internal and external standards in difficult contexts. Their nervous system has adapted, through neuroplastic processes, to a life lived between incompatible imperatives. Pain is not imagined. It is an embodied signal that the way they have been solving fundamental human dilemmas is no longer sustainable.

The advantage of this model for both clinicians and patients is that it provides a clear target: not “stress” in the abstract, but this person’s specific, lived conflicts and the emotional rules that keep those conflicts frozen. It links directly to known mechanisms—central sensitization, descending modulation, allostatic load, limbic–prefrontal dysregulation—and provides a rationale for why working on conflict resolution, emotional awareness, and values-based action is not “just psychological,” but a direct way of altering the biology of pain. Pain Resolution Therapy’s Inner Conflict Circuit model therefore offers a way out of the unhelpful dichotomy between “mind” and “body,” and between “structural” and “psychological” explanations. It locates psychophysiologic pain squarely within the nervous system’s predictive, integrative, conflict-sensitive architecture and invites both therapist and patient to work precisely where the system is stuck.

The Trauma–Pain Connection

Adverse Childhood Experiences and Chronic Pain

How early life stress shapes adult pain neurobiology.

0:00—

The relationship between childhood trauma and chronic pain in adulthood has emerged as one of the most robust findings in pain research over the past two decades. A systematic review and meta-analysis synthesizing 75 years of research involving over 826,000 adults reveals that individuals exposed to adverse childhood experiences are 45 percent more likely to report chronic pain in adulthood compared to those not exposed. This association is not weak or speculative. It is strong, dose-dependent, and present across cultures, pain conditions, and research methodologies. Physical abuse shows the strongest association with both chronic pain and pain-related disability. Emotional abuse correlates particularly with diffuse, widespread pain. The risk increases systematically with cumulative exposure. One adverse childhood experience raises risk modestly. Four or more adverse childhood experiences substantially amplify the likelihood of chronic pain decades later. Over one billion children globally, representing half the world's child population, are exposed to adverse childhood experiences each year. This means hundreds of millions of people are being primed during their developmental years for chronic pain that will emerge in adulthood, creating suffering, disability, and economic burden on a massive scale.

Adverse childhood experiences, commonly abbreviated as ACEs, are defined as potentially traumatic events occurring before age eighteen. They include direct experiences such as physical abuse, sexual abuse, emotional abuse, and neglect by primary caregivers. They also include indirect environmental exposures such as witnessing domestic violence, living with a parent who has substance use disorder or mental illness, experiencing parental separation or divorce, or having a household member incarcerated. The original ACE study, conducted by Kaiser Permanente and the Centers for Disease Control in the mid-1990s, established that these experiences are both common and profoundly damaging to long-term health. Subsequent research has demonstrated associations between ACEs and virtually every major chronic disease including cardiovascular disease, diabetes, cancer, autoimmune conditions, and psychiatric disorders. Chronic pain fits squarely within this pattern. It is not an exception. It is one of the most consistent outcomes associated with childhood adversity.

The question that has occupied researchers for decades is how childhood trauma, which may have occurred thirty, forty, or fifty years before pain onset, exerts such lasting influence. The answer cannot be found in peripheral tissues. There is no mechanism by which emotional abuse at age seven causes spinal disc degeneration at age forty-five. The mechanism must reside in the nervous system itself, in the long-term changes that trauma produces in how the brain and body respond to threat, regulate stress, process emotion, and construct pain. These changes are not psychological in a dismissive sense. They are neurobiological. They involve measurable alterations in brain structure, connectivity, neurochemistry, immune function, and gene expression. Understanding these mechanisms is essential for clinicians working with chronic pain, because it explains why pain in trauma-exposed individuals often defies traditional medical treatments and requires approaches that address the nervous system's learned patterns of threat detection and response.

The hypothalamic-pituitary-adrenal axis, commonly referred to as the HPA axis, represents the body's primary stress response system. When threat is detected, the hypothalamus secretes corticotropin-releasing hormone. This hormone travels to the pituitary gland, triggering release of adrenocorticotropic hormone into the bloodstream. Adrenocorticotropic hormone reaches the adrenal glands atop the kidneys, stimulating production and release of cortisol, the body's main stress hormone. Cortisol mobilizes energy, suppresses non-essential functions, and enhances the body's capacity to respond to danger. The system operates as a negative feedback loop. Cortisol travels back to the hypothalamus and pituitary, binding to glucocorticoid receptors that signal the system to reduce further hormone release. In healthy individuals facing acute stress, the HPA axis activates rapidly, peaks, and then returns to baseline once the stressor resolves. This adaptive response protects the organism during genuine threat while minimizing the physiological costs of sustained activation.

Childhood trauma fundamentally alters HPA axis function. The developing nervous system of a child exposed to chronic threat, unpredictability, or overwhelming emotion is shaped by that environment. The HPA axis, designed to respond to occasional acute stressors, becomes chronically activated. This prolonged activation during critical periods of neurodevelopment causes lasting changes. Research consistently demonstrates HPA axis dysregulation in individuals with histories of childhood trauma. The specific pattern of dysregulation is complex and sometimes counterintuitive. Many trauma-exposed individuals show blunted cortisol responses, with lower baseline cortisol and reduced cortisol reactivity to stress. This appears paradoxical. If the system is chronically activated during childhood, why would cortisol be low in adulthood? The explanation involves compensatory changes. Chronic activation leads to upregulation of glucocorticoid receptors and enhanced negative feedback sensitivity. The system becomes hypersensitive to cortisol, shutting down the stress response prematurely even when cortisol levels are low. The result is a system that cannot mount adequate responses to new stressors and cannot effectively regulate inflammation.

This HPA axis dysfunction has direct consequences for pain. Cortisol is a powerful anti-inflammatory hormone. When cortisol regulation is impaired, inflammatory processes go unchecked. Individuals with trauma histories show elevated levels of inflammatory biomarkers including interleukin-6, tumor necrosis factor-alpha, and C-reactive protein. Chronic inflammation sensitizes peripheral nociceptors, lowering their activation thresholds and increasing their responsiveness. It also promotes central sensitization. Inflammatory mediators cross the blood-brain barrier, activating microglia, the brain's immune cells. Activated microglia release pro-inflammatory cytokines and other neuromodulators that enhance synaptic transmission in pain pathways. Early life stress primes microglia to overrespond to subsequent challenges, creating a state of persistent neuroinflammation. This combination of peripheral sensitization from systemic inflammation and central sensitization from neuroinflammation establishes the biological substrate for chronic pain.

Beyond inflammation, HPA axis dysfunction alters pain processing directly. The hypothalamus, pituitary, and adrenal hormones interact with brain regions involved in pain modulation. Corticotropin-releasing hormone, the initiating signal of the HPA axis, is produced not only in the hypothalamus but also in other brain regions including the amygdala and brainstem areas involved in descending pain control. In the central nervous system, corticotropin-releasing hormone acts as a stress signal, increasing anxiety, vigilance, and pain sensitivity. When HPA axis regulation is disrupted, corticotropin-releasing hormone levels can remain elevated even in the absence of acute threat, maintaining the nervous system in a state of heightened reactivity. Cortisol itself modulates pain perception through actions on glucocorticoid receptors in pain-processing regions. Dysregulated cortisol responses mean that the body's natural analgesic mechanisms function improperly. Pain that should be dampened by stress-induced analgesia is instead amplified.

Structural and functional brain changes provide another pathway linking childhood trauma to chronic pain. Neuroimaging studies document consistent alterations in trauma-exposed individuals. The amygdala, the brain's threat detection center, shows increased volume and heightened reactivity in children and adults with trauma histories. This enlarged, hyperactive amygdala biases perception toward threat, interpreting ambiguous stimuli as dangerous and generating exaggerated fear responses. In the context of pain, an overactive amygdala means that bodily sensations are more likely to be interpreted as threatening, triggering pain amplification through emotional and attentional mechanisms. The hippocampus, critical for memory and context discrimination, shows reduced volume following childhood trauma. A smaller, less functional hippocampus impairs the ability to distinguish past from present, contributing to flashbacks and intrusive memories. It also impairs contextual modulation of pain, making it difficult for the person to recognize that sensations occurring in safe current contexts do not require the same protective responses that were necessary during past danger.

The prefrontal cortex, responsible for executive function, emotional regulation, and top-down control of subcortical structures, shows both structural and functional alterations after childhood trauma. Gray matter reductions are documented in orbitofrontal cortex and dorsolateral prefrontal cortex. White matter integrity in tracts connecting prefrontal cortex to amygdala, hippocampus, and reward circuitry is reduced. Functionally, prefrontal regions show decreased activation during emotion regulation tasks and reduced connectivity with limbic structures. This prefrontal dysfunction has profound implications for pain. The prefrontal cortex is a key component of descending pain modulation systems. It exerts top-down control over pain processing in the spinal cord and brainstem. When prefrontal function is compromised, descending inhibition weakens and descending facilitation strengthens. The balance shifts toward pain amplification. Additionally, prefrontal dysfunction impairs cognitive strategies for managing pain, such as reappraisal, distraction, and perspective-taking. Individuals struggle to regulate their emotional responses to pain, leading to catastrophizing, rumination, and helplessness.

Connectivity changes within pain and emotion networks further explain the trauma-pain link. Resting-state functional MRI studies show altered connectivity patterns in trauma-exposed individuals. Regions of the default mode network, involved in self-referential processing and internal focus, show increased connectivity with pain-processing regions. This means that even at rest, the brain maintains heightened coupling between networks that support rumination and networks that construct pain. The salience network, which detects and prioritizes important stimuli, shows hyperconnectivity in trauma survivors. An overactive salience network directs attention persistently toward pain and threat-related cues, preventing the person from disengaging from pain even when it would be adaptive to do so. Reward circuitry, including ventral striatum and connections to prefrontal cortex, shows blunted responses to positive stimuli in individuals with early life stress. This anhedonia, the reduced capacity to experience pleasure, eliminates a natural buffer against pain. When positive experiences fail to activate reward systems, pain becomes the dominant signal demanding attention.

Neurochemical changes provide additional mechanisms. Childhood trauma alters neurotransmitter systems involved in both stress response and pain modulation. Norepinephrine, a key player in vigilance and arousal, shows dysregulation with increased sympathetic nervous system activity and elevated norepinephrine levels in some trauma survivors. This heightened sympathetic tone maintains the body in fight-or-flight mode, amplifying pain sensitivity. Serotonin, which modulates mood, anxiety, and descending pain inhibition, is disrupted in trauma-exposed populations. Lower serotonin availability correlates with increased depression and reduced pain inhibition. Dopamine, central to reward, motivation, and prediction error signaling, shows altered function in individuals with adverse childhood experiences. Blunted dopamine responses to positive outcomes reduce motivation and contribute to the sense that efforts to improve are futile, perpetuating disability. The endogenous opioid system, the body's natural pain relief mechanism, shows reduced activity in chronic pain patients with trauma histories. Endogenous opioids are released during stress-induced analgesia, placebo responses, and social connection. When this system is impaired, natural analgesic mechanisms fail.

Epigenetic changes provide a mechanism for long-term embedding of trauma effects. Epigenetics refers to modifications in gene expression that occur without changes to the DNA sequence itself. Chemical modifications such as methylation of DNA or acetylation of histone proteins alter how accessible genes are for transcription. Childhood trauma produces epigenetic changes in genes involved in stress response, immune function, and neurodevelopment. The FKBP5 gene, which modulates glucocorticoid receptor sensitivity, shows altered methylation patterns in trauma-exposed individuals. This change affects HPA axis function across the lifespan. The NR3C1 gene, encoding the glucocorticoid receptor itself, similarly shows epigenetic modifications following early adversity. Genes involved in inflammatory responses such as IL6 and TNF-alpha show altered regulation. These epigenetic modifications can be long-lasting, persisting decades after the trauma occurred. They may even be transmitted across generations, affecting the stress reactivity and pain sensitivity of offspring who were not directly exposed to trauma. This biological embedding of adversity explains how experiences in childhood can shape physiology and health throughout life.

Psychological and interpersonal factors mediate the relationship between childhood trauma and chronic pain, but they operate through biological mechanisms rather than existing separately from them. Alexithymia, the difficulty identifying and describing one's own emotions, is more common in individuals with trauma histories. When a person cannot recognize or articulate emotional states, those states are more likely to be expressed through physical symptoms including pain. This is not conversion or somatization in the dismissive psychodynamic sense. It reflects the fact that emotional and physical pain share overlapping neural circuitry. When emotional awareness is impaired, the brain defaults to physical expression. Catastrophizing, the tendency to magnify the threat value of pain and feel helpless to manage it, is elevated in trauma survivors. Catastrophizing is not simply negative thinking. It reflects a genuinely heightened threat detection system trained by past experiences where catastrophic outcomes did occur. When danger was unpredictable and uncontrollable in childhood, expecting the worst became adaptive. That learned expectation persists into adulthood, biasing pain predictions toward maximum threat.

Fear-avoidance behavior, where individuals avoid activities they believe will cause pain or injury, is more pronounced in those with trauma backgrounds. This avoidance is overdetermined. Childhood experiences of being hurt, of boundaries being violated, or of having no control over what happens to one's body teach vigilance and withdrawal. When pain develops in adulthood, those learned protective strategies are reactivated. The person avoids movement, social engagement, or emotional experience, creating deconditioning, isolation, and emotional suppression that paradoxically worsen pain. External locus of control, the belief that outcomes are determined by forces outside oneself, develops when childhood environments were chaotic, unpredictable, or controlled by abusive caregivers. This belief undermines engagement with treatment, because the person does not expect that their actions will produce meaningful change. Social support, which powerfully buffers against pain and facilitates recovery, is often impaired in trauma survivors. Childhood abuse and neglect disrupt attachment, making it difficult to trust others, ask for help, or maintain supportive relationships. The absence of social support removes a key protective factor and increases vulnerability to chronic pain.

The dose-response relationship between adverse childhood experiences and chronic pain is particularly striking. Meta-analytic evidence shows that risk increases systematically with the number of adverse experiences. One ACE produces a modest increase in pain risk. Two ACEs increase risk further. Four or more ACEs produce substantially elevated risk. This cumulative effect suggests that the mechanisms are additive or synergistic. Each additional trauma adds to HPA axis dysregulation, increases inflammatory burden, further impairs prefrontal function, and deepens the expectation that the world is dangerous. By the time an individual has experienced multiple forms of childhood adversity, their nervous system has been profoundly shaped toward threat detection, hypervigilance, and pain amplification. This is not weakness. It is an adaptive response to an environment that was genuinely threatening. The nervous system learned the lessons that environment taught. The problem is that those lessons, adaptive in childhood, become maladaptive when the environment changes but the nervous system's learned responses do not.

The type of adverse childhood experience matters. Physical abuse shows the strongest association with both chronic pain and disability. The direct experience of bodily harm creates powerful associations between physical sensations and danger. When pain develops in adulthood, it reactivates those associations, triggering protective responses far out of proportion to actual threat. Sexual abuse similarly creates intense bodily threat associations and also produces profound shame, dissociation, and disconnection from the body. Many survivors of sexual abuse report that they do not feel safe in their own bodies, a subjective experience that has neurobiological correlates in altered body representation and interoceptive processing. Emotional abuse, while lacking the direct physical component, correlates particularly strongly with diffuse, widespread pain syndromes such as fibromyalgia. Emotional abuse teaches that one is worthless, unlovable, or fundamentally flawed. That internalized message creates chronic psychological threat and shame, maintaining autonomic arousal and nervous system vigilance even in the absence of external danger. Neglect, the failure to provide adequate care, nurturance, or emotional attunement, produces deficits in self-regulation, emotional awareness, and stress coping. Children who were neglected did not learn how to soothe themselves, recognize their needs, or seek help appropriately. These deficits persist into adulthood, leaving individuals ill-equipped to manage pain or engage in self-care.

The mechanisms linking childhood trauma to chronic pain are not psychological in the sense of being less real than physical mechanisms. They are psychobiological. They involve the same nervous system structures and processes that mediate all pain experience. The distinction between physical and psychological becomes meaningless at this level of analysis. What we see instead is a unified system in which early experiences shape neural development, alter stress physiology, modulate immune function, bias threat detection, and ultimately influence whether sensory signals are constructed as pain. This understanding has profound implications for treatment. Approaches that ignore trauma history and focus solely on biomechanical factors or pharmacological suppression of symptoms will fail in trauma-exposed populations. The pain is not maintained by peripheral pathology. It is maintained by a nervous system that learned to detect threat everywhere and to respond with protection even when no danger exists.

Pain Resolution Therapy is explicitly designed to address the mechanisms linking trauma to chronic pain. The framework recognizes that chronic pain in trauma survivors functions as a continuation of protective responses that were necessary in childhood but are no longer appropriate. The reattribution component helps clients understand that their pain is not evidence of tissue damage but rather evidence that their nervous system remains in a threat state. This cognitive shift reduces fear and begins to update threat predictions. The emotional processing component directly addresses the unprocessed trauma maintaining nervous system dysregulation. Suppressed anger, unacknowledged fear, ungrieved loss, and unprocessed shame all maintain HPA axis activation, inflammatory tone, and limbic hyperactivity. When these emotions are identified, expressed, and integrated, autonomic arousal decreases. The nervous system receives the message that the threat has been acknowledged and no longer requires a constant alarm signal. The conflict resolution component addresses the ways trauma survivors organize their adult lives around protection, people-pleasing, and hypervigilance. When a person identifies that their pain worsens when they cannot set boundaries, when they suppress authentic needs, or when they remain in relationships that recreate childhood dynamics, the pattern becomes visible. Resolving these conflicts updates the nervous system's assessment that danger is present.

Behavioral experiments provide corrective experiences that directly contradict the predictions learned in childhood. A trauma survivor whose nervous system predicts that vulnerability leads to harm can test that prediction through graded exposure to emotional expression in the safety of the therapeutic relationship. A person whose body learned that movement provokes injury can test that prediction through carefully titrated physical activity that demonstrates safety. These experiments generate prediction errors. The feared outcome does not occur. The nervous system updates its models. With repeated experiences of safety, the brain learns that it can reduce vigilance, that it can allow rest, that pain is not required as protection. This is not cognitive restructuring in the sense of changing thoughts. It is experiential learning that produces neuroplastic change in the same circuits that trauma originally shaped.

The evidence linking childhood trauma to chronic pain is no longer debatable. The mechanisms are increasingly well-understood. HPA axis dysfunction produces inflammatory and stress-response abnormalities. Brain structural changes in amygdala, hippocampus, and prefrontal cortex alter threat detection and pain modulation. Neurochemical dysregulation impairs natural analgesic systems. Epigenetic modifications embed trauma effects at the level of gene expression. Psychological patterns such as catastrophizing, fear-avoidance, and alexithymia reflect and perpetuate these neurobiological changes. The dose-response relationship and specificity of associations with particular trauma types strengthen causal inference. For clinicians, this evidence demands a trauma-informed approach to chronic pain. Screening for adverse childhood experiences should be routine. When trauma history is present, treatment must address the nervous system's learned threat responses rather than focusing solely on symptoms. Pain Resolution Therapy provides a structured framework for this work, integrating neuroscience understanding of trauma effects with practical interventions that target the mechanisms maintaining pain. The fact that childhood experiences decades past continue to influence adult pain is not mysterious or psychological in a dismissive sense. It is neurobiology. The nervous system remembers. Pain Resolution Therapy teaches it to learn something new.

Small Effects and the Unaddressed Emotional Core

Why CBT Doesn't Resolve Psychosomatic Pain

Why standard cognitive-behavioral therapy often fails to resolve chronic pain.

0:00—

Cognitive-behavioral therapy has dominated psychological treatment for chronic pain for more than three decades. It is the most widely studied, most endorsed, and most disseminated psychological intervention for persistent pain. Hundreds of clinical trials have evaluated CBT protocols. Dozens of meta-analyses have synthesized those trials. Major practice guidelines consistently identify CBT as a first-line option. Many multidisciplinary pain programs include some form of CBT as standard care. For patients seeking help, CBT is often the only psychological intervention available. Yet when we examine the empirical record with care, a striking gap appears between CBT's reputation and its actual efficacy for chronic pain.

The most authoritative synthesis of this evidence is the 2020 Cochrane review by Williams and colleagues, which pooled 59 randomized controlled trials of CBT involving over 5,000 participants with chronic pain excluding headache. The review's conclusions were unambiguous. CBT, compared with active control treatments such as education or exercise, showed very small benefits at treatment end for pain, with a standardized mean difference of negative 0.09. For disability, effects were small. For distress, effects were small. When CBT was compared with treatment as usual or wait-list, effect sizes were slightly larger, but still small or very small across outcomes. Six to twelve months after treatment, pain and distress effects persisted only when CBT was compared with wait-list or treatment as usual, not when compared with active controls. Disability effects, already small, largely disappeared at follow-up. The authors' conclusion was stark: "CBT has small or very small beneficial effects for reducing pain, disability, and distress in chronic pain."

These are not isolated or outlier findings. A 2014 meta-analysis by Ehde and colleagues examining CBT for chronic pain found that while CBT produced statistically significant effects on pain compared with treatment-as-usual or wait-list controls, the effects were small. Compared with active control conditions, CBT did not demonstrate consistent superiority. Among studies measuring clinically significant improvement, defined as at least 50 percent pain reduction, CBT-based interventions achieved this benchmark in a minority of participants. A 2022 meta-analysis of internet-delivered cognitive and behavioral interventions for chronic pain found small effect sizes for pain interference, disability, and pain intensity. Even with clinician guidance, effect sizes remained modest. A 2023 systematic review of CBT-based interventions for chronic pain with comorbid emotional disorders found that traditional CBT produced significant differences in depression and anxiety reduction in some trials, but improvements in pain intensity and interference were minimal or absent.

What do these numbers mean in clinical terms? A recent large-scale randomized trial of remote-delivered CBT-based chronic pain treatment involving 2,331 patients reported that 32 percent of participants in the health coach-led CBT group achieved at least 30 percent pain reduction at three months, compared with 20.8 percent in usual care. That is a statistically significant difference, and it is better than nothing. But it also means that roughly two-thirds of participants receiving CBT did not achieve even a 30 percent reduction in pain—a threshold often considered the minimum clinically important difference. When the bar is raised to 50 percent pain reduction, typical CBT trials report success rates between 14 and 33 percent, with many studies clustering in the lower part of that range. For the majority of patients who seek CBT for chronic pain, meaningful symptom resolution does not occur.

This is not to suggest that CBT is useless. Small effects, applied at population scale, can produce meaningful public health benefit. For patients who are catastrophizing intensely, fearful of movement, or stuck in complete inactivity, CBT's emphasis on challenging distorted thoughts, graded exposure, and behavioral activation can provide structure, hope, and modest functional gains. Many patients do report feeling better equipped to manage their pain, even when pain intensity itself changes little. CBT teaches real skills. The problem is not that CBT offers nothing. The problem is that, for the majority of patients with chronic psychophysiologic pain, CBT does not address the mechanisms maintaining their symptoms.

Standard CBT for chronic pain is a skills-training model. It typically involves psychoeducation about the biopsychosocial nature of pain, instruction in relaxation and breathing techniques, cognitive restructuring to challenge catastrophic or unhelpful beliefs about pain, activity pacing and goal-setting to increase function, and problem-solving for specific barriers to engagement in life. The model assumes that maladaptive thoughts and behaviors are the primary drivers of pain and disability, and that modifying these will improve outcomes. This assumption is reasonable and partially true. Catastrophizing—the tendency to magnify threat, ruminate on pain, and feel helplessly—does predict worse pain and disability. Fear of movement can lead to deconditioning and further pain. Inactivity reinforces the belief that the body is fragile. Targeting these patterns makes sense.

What CBT typically does not do, however, is directly engage with the emotional and relational content that underlies catastrophizing, fear, and avoidance in the first place. A patient may be taught to recognize and dispute the thought "My back is damaged and I will be disabled forever," replacing it with a more balanced alternative like "My back is sensitive, but movement is safe and will help me." This cognitive shift can reduce anxiety and support a graded return to activity. But it does not address why the person's nervous system learned to interpret sensations as dangerous, what life circumstances or unresolved conflicts are maintaining that hypervigilance, or what emotions—anger, grief, shame, fear—are being suppressed and expressed somatically. CBT operates largely at the surface of thought and behavior. It rarely ventures into the emotional depths where chronic pain, especially centralized pain, is rooted.

Most patients with chronic psychophysiologic pain carry histories that CBT protocols do not systematically assess or address. They have elevated rates of adverse childhood experiences, trauma, unresolved grief, suppressed anger, and chronic role strain. Many are living inside impossible internal dilemmas: duty versus rest, authenticity versus approval, anger versus peace-keeping, self-protection versus loyalty. These conflicts generate sustained nervous system arousal and maintain central sensitization. They are not simply "negative thoughts" that can be disputed through Socratic questioning. They are lived predicaments with deep emotional stakes. When a patient catastrophizes about pain, the catastrophizing is often not irrational. It reflects a genuinely dangerous life situation—emotional, relational, or existential—that the person has no clear way to resolve. Teaching them to reframe their thoughts without addressing the underlying conflict can feel invalidating and may produce only transient benefit.

CBT also does not systematically work with emotional expression and processing. Many chronic pain patients have learned, often from childhood, that expressing emotions—especially anger, sadness, or vulnerability—is unsafe. Their families punished anger, dismissed sadness, or required them to suppress their own needs in service of others. As adults, they maintain these patterns. They smile when they are resentful. They stay silent when they are furious. They care for everyone while neglecting themselves. The emotions do not disappear. They are driven into the body, where they maintain autonomic arousal, muscle tension, and pain amplification. Standard CBT might acknowledge that emotions influence pain, but it typically treats emotions as something to regulate or reduce through relaxation or distraction, not as signals requiring acknowledgment, expression, and integration.

This limitation is not incidental; it is structural. CBT emerged from a cognitive and behavioral tradition that prioritized observable thoughts and actions over subjective emotional experience. While contemporary CBT has evolved to incorporate more emotion-focused elements, many protocols for chronic pain remain firmly anchored in the skills-training model. Therapists are trained to deliver structured modules on pacing, activity scheduling, and cognitive restructuring. They are less often trained to help patients sit with and move through intense anger, grief, or shame, or to identify and resolve the internal conflicts driving those emotions. The result is a treatment that can help patients cope better with pain but does not usually resolve the pain itself.

Recent evidence underscores this gap. A 2024 randomized controlled trial by Yarns and colleagues directly compared emotional awareness and expression therapy with CBT in 126 older veterans with chronic musculoskeletal pain. EAET is a short-term psychological intervention explicitly designed to help patients recognize, express, and resolve trauma-related emotions and internal conflicts that maintain pain. The trial found that EAET was significantly superior to CBT on the primary outcome of pain severity reduction at both post-treatment and six-month follow-up. At post-treatment, 63 percent of EAET participants achieved at least 30 percent pain reduction, compared with only 17 percent in CBT. For 50 percent pain reduction, the numbers were 35 percent versus 7 percent. EAET was also superior to CBT on secondary outcomes including anxiety, depression, life satisfaction, PTSD symptoms, and patient global impression of change. These differences were not marginal. They were large, clinically significant, and sustained.

This trial is not an isolated finding. An earlier trial in fibromyalgia by Lumley and colleagues found that EAET was numerically superior to CBT on all but one of 15 outcomes and significantly superior on reductions in widespread pain and the percentage of patients reaching 50 percent pain reduction. A meta-analysis and systematic review of emotion regulation interventions for chronic pain concluded that emotion-focused approaches produced larger effects than CBT on pain and affective distress. Internet-delivered EAET has shown medium effect sizes on somatic symptoms maintained at 12-month follow-up, with responder rates comparable to or better than those typically seen in internet-delivered CBT for similar populations. Hybrid emotion-focused exposure interventions combining CBT with trauma processing and emotional expression have demonstrated significantly better outcomes on pain catastrophizing, pain interference, and depression compared with standard internet-delivered CBT.

These findings point to a clear conclusion. The element that standard CBT lacks—direct engagement with trauma, suppressed emotions, and internal conflicts—is precisely the element that drives the superior outcomes of emotion-focused interventions. When therapies help patients access, express, and resolve the emotional material underlying their pain, pain reduction is larger and more frequent than when therapies focus primarily on teaching coping skills and modifying thoughts.

Pain Resolution Therapy is built on this insight. It does not reject the value of behavioral activation, graded exposure, or cognitive restructuring. These techniques have their place, especially when patients are severely deconditioned, highly avoidant, or rigidly stuck in catastrophic thinking. But Pain Resolution Therapy does not stop there. It positions these techniques within a larger framework that treats emotional processing and conflict resolution as primary, not secondary. The model assumes that most chronic psychophysiologic pain is maintained by unresolved emotional material and by internal conflicts that keep the nervous system in a sustained threat state. The therapeutic task, therefore, is not just to help patients think differently or move more. It is to help them feel differently, choose differently, and ultimately teach their nervous system that the body is safe.

The reattribution component of Pain Resolution Therapy helps patients understand that their pain is generated by a sensitized nervous system responding to learned threat predictions, not by ongoing tissue damage. This cognitive shift is similar to what happens in CBT, but it is tied explicitly to neuroscience and the patient's own conflict map. The emotional processing component goes beyond what CBT typically offers. It involves identifying suppressed emotions—anger at unfair treatment, grief over unmet needs, fear of abandonment, shame about perceived failure—and creating safe opportunities to feel, express, and integrate those emotions. This is not catharsis for its own sake. It is the deliberate updating of a nervous system that has learned to express emotional distress through pain because direct emotional expression was not safe.

The conflict resolution component, unique to Pain Resolution Therapy, addresses the chronic internal dilemmas that maintain threat signals. Patients are helped to map their central conflicts: "I must keep everyone happy or I am worthless" versus "If I keep doing that, I will collapse." They are guided to see how these conflicts show up in their daily lives and how pain spikes when the conflict is most active. They are supported to design small behavioral experiments that test the edges of the conflict—saying no once, resting openly, expressing one honest need—and to observe what happens, both in relationships and in their bodies. Over time, these experiments generate new experiences that disconfirm the nervous system's threat predictions. Pain becomes less necessary as protection.

This is not a subtle difference from CBT. It is a fundamental reorientation. Where CBT says, "Let's help you cope better with the pain you have," Pain Resolution Therapy says, "Let's figure out why your nervous system is generating pain and change that." Where CBT teaches patients to relax, pace, and reframe, Pain Resolution Therapy teaches patients to feel, resolve, and act. Where CBT targets symptoms, Pain Resolution Therapy targets mechanisms. The outcome data reflect this distinction. While CBT produces small effects and helps 14 to 33 percent of patients achieve clinically significant improvement, emotion-focused interventions like EAET achieve these benchmarks in 35 to 63 percent of patients, with larger effect sizes and better-maintained gains.

For clinicians trained in CBT, this evidence can be unsettling. Many have invested years in learning and delivering CBT protocols. They have seen patients benefit, at least modestly. The idea that CBT may not be sufficient—or even, in some cases, that it may be missing the point—challenges professional identity and institutional inertia. But the evidence is clear. For chronic pain, especially centralized or psychophysiologic pain, standard CBT is not the gold standard. It is a reasonable starting point for some patients, but it leaves the emotional and conflict-driven core of the problem untouched. As Lumley and Schubiner noted in their commentary on the EAET-versus-CBT trial, "To feel is to heal." Chronic pain maintained by unresolved emotional experience and internal conflict requires interventions that help patients feel, not just think and behave differently.

This does not mean that every element of CBT should be discarded. Behavioral activation, graded exposure, and cognitive restructuring remain useful tools, especially when integrated within a framework that also addresses emotional processing and conflict resolution. Some CBT-trained therapists are already moving in this direction, incorporating trauma-informed practices, emotional expression techniques, and values-based work into their pain protocols. What is needed is not the abandonment of CBT but its subordination within a more comprehensive model that recognizes chronic pain as fundamentally an issue of nervous system learning driven by emotional and relational patterns, not primarily a problem of distorted cognition.

Pain Resolution Therapy represents this shift. It retains what is useful from CBT—graded behavioral change, cognitive reattribution, structured goal-setting—but embeds these within a treatment that prioritizes emotional awareness, expression, and conflict resolution. It does not ask patients to manage pain better. It asks them to understand why pain is present, to feel what has been unfelt, to resolve what has been unresolvable, and to give their nervous system new evidence that threat has passed. For the majority of chronic pain patients who have tried CBT and found it insufficient, this approach offers what has been missing: direct engagement with the emotional and relational mechanisms maintaining their pain.

Low-Quality Evidence and Missing Mechanisms

Mindfulness for Chronic Pain: Nearly Useless

Why mindful observation alone rarely resolves a sensitized nervous system.

0:00—

Mindfulness-based interventions, particularly mindfulness-based stress reduction, have become enormously popular for chronic pain. Workshops, online courses, and pain management programs routinely incorporate mindfulness meditation. The approach is appealing in its simplicity and accessibility. Patients learn to observe pain without judgment, to breathe through discomfort, and to cultivate acceptance rather than resistance. Proponents claim that mindfulness changes how people relate to pain, reducing suffering even when pain intensity persists. These claims have some support, but when the evidence is examined systematically, a more ambiguous picture emerges. Mindfulness does help some patients some of the time, particularly with humanistic and emotional outcomes. But the quality of evidence is low, the effects on pain and disability are small and inconsistent, and the mechanisms of action remain unclear. Perhaps most importantly, mindfulness as typically practiced does not systematically address the emotional conflicts, trauma histories, and maladaptive predictions that drive central sensitization in chronic psychophysiologic pain.

The most comprehensive systematic review and meta-analysis of mindfulness meditation for chronic pain pooled 38 randomized controlled trials. The authors applied the GRADE approach to rate the quality of evidence and used rigorous meta-analytic methods to calculate effects. Their conclusion was unambiguous: they found low-quality evidence that mindfulness meditation is associated with a small decrease in pain compared with all types of controls. While statistically significant effects were also found for depression symptoms and quality of life, the authors emphasized that additional well-designed, rigorous, and large-scale trials are needed to decisively provide estimates of efficacy. Previous reviews had echoed concerns that there is limited evidence for the efficacy of mindfulness-based interventions for chronic pain because of methodological issues, and that additional high-quality research was needed before recommendations could be made.

A more recent umbrella review synthesized 21 meta-analyses that included 127 unique studies of mindfulness-based interventions in pain. This synthesis revealed that results are "more mixed than they at first appear." While there was an overall impact of mindfulness interventions on pain severity, anxiety, and depression, there was no significant effect on pain interference or disability. When conditions were examined in isolation, only fibromyalgia and headache showed significant benefit from mindfulness-based interventions. Crucially, mindfulness-based interventions were more efficacious for pain severity than passive control conditions, such as wait-list or usual care, but not when compared with active control conditions like education or other psychological treatments. The authors concluded that individual meta-analyses may have overestimated the efficacy of mindfulness-based interventions in a range of conditions, and that while mindfulness interventions likely have a role in pain management, they should not be considered a panacea.

Specific reviews of mindfulness-based stress reduction for chronic low back pain, one of the most common chronic pain presentations, reflect this tempered enthusiasm. A systematic review and meta-analysis of seven trials involving 864 patients found that studies measuring pain intensity and pain-related disability found small improvements with MBSR only over the short term, and even these improvements were of questionable clinical significance. Some studies showed meaningful short-term improvements in physical functioning, but improvements were not sustained long-term. Surprisingly, MBSR was not associated with improvements in mindfulness or acceptance of pain in either the short or long term, raising questions about the mechanisms of any observed benefit. One trial found no difference between MBSR and education programs in terms of disability, pain-related quality of life, sick leave, or analgesic use, and concluded that MBSR was not superior to multidisciplinary education for chronic pain.

Evidence quality is a recurring theme. Across reviews, the quality of included trials is frequently rated as low or very low due to small sample sizes, lack of blinding, high dropout rates, selective outcome reporting, and inconsistent use of validated measures. A meta-analysis of mindfulness-based interventions for fibromyalgia, one of the conditions where effects appear most promising, found low-quality evidence for short-term improvement in pain and quality of life, with effects not resilient against bias and no evidence of long-term effects. A more recent observational study of MBSR for chronic pain in intensive care unit survivors noted that while results were statistically significant, they did not appear to be clinically relevant, and called for further studies with larger samples and control groups.

What do these findings mean in practical terms? Mindfulness-based stress reduction programs typically involve eight weekly group sessions of two to three hours, plus daily home practice of 45 minutes to an hour. That is a substantial time commitment. When this commitment yields, on average, a small, short-term decrease in pain that is indistinguishable from the effect of education or other active treatments, it is difficult to position mindfulness as a primary solution for chronic pain. For some individuals, particularly those high in trait mindfulness or those who find meditation intrinsically rewarding, the benefits may be meaningful and sustained. For many others, the investment produces modest or negligible pain relief.

Interestingly, the effects of mindfulness-based stress reduction on psychological outcomes such as acceptance, depression, anxiety, and stress are somewhat more robust and consistent than effects on pain intensity or disability. A recent eye-tracking study of MBSR in chronic back pain found that the program produced significant improvements in depression, anxiety, stress, pain acceptance, overall well-being, and life satisfaction. However, it had limited impact on attentional patterns to pain stimuli, with only a small increase in the ability to maintain attention across stimuli. The authors concluded that despite MBSR's success in reducing symptoms associated with chronic pain, the lack of broader attentional improvements raised questions about the mechanisms responsible for psychological improvements.

From a mechanistic perspective, mindfulness practices are thought to work by enhancing present-moment awareness, reducing reactivity to sensations and thoughts, and cultivating equanimity in the face of discomfort. Neuroimaging studies show that experienced meditators exhibit altered activity in brain regions involved in pain processing, attention, and emotion regulation, including reduced activity in areas associated with the unpleasantness of pain and enhanced activity in prefrontal areas supporting cognitive control. In experimental pain paradigms, mindfulness training can reduce pain ratings, increase pain tolerance, and modulate descending pain pathways. These are genuine and interesting effects. However, they are primarily regulatory effects. Mindfulness helps people respond differently to sensations that are already being generated. It does not, by itself, change what the nervous system has learned to predict as dangerous.

In chronic psychophysiologic pain, the core problem is that the nervous system has learned, through experience, that certain movements, contexts, emotions, or conflicts signal threat. Pain is generated proactively as a protective response to these predictions. Central sensitization is maintained by a combination of persistent threat predictions, unresolved emotional experiences, and internal role conflicts that keep autonomic arousal high. Mindfulness, as typically taught, does not systematically identify or address these drivers. It teaches patients to observe pain with acceptance and curiosity rather than fear or resistance. This can reduce suffering in the sense of psychological distress about the pain. But it does not necessarily change the underlying conflicts, traumas, or maladaptive predictions that are feeding the sensitized state.

For example, a patient whose pain flares when they feel guilt about resting or anger about unequal family burdens may learn through mindfulness to breathe through the flare and observe the sensations without judgment. This may reduce catastrophizing and secondary distress. But it does not help them recognize that the flare is linked to an internal conflict between duty and self-care, or that their nervous system is responding to the guilt and anger as threats. It does not guide them to express the anger, process the grief, or resolve the conflict by making concrete changes in their roles and boundaries. Without this deeper work, the same patterns of guilt and suppressed anger recur, and so does the pain.

Mindfulness programs also do not systematically incorporate trauma processing or address adverse childhood experiences, despite strong evidence that trauma histories are prevalent in chronic pain populations and are key drivers of central sensitization. While some mindfulness teachers acknowledge trauma and emphasize the importance of safety, standard MBSR protocols do not include structured methods for identifying trauma-related triggers, processing traumatic memories, or resolving the relational and identity wounds that trauma leaves behind. Trauma-sensitive adaptations of mindfulness have been developed, but they are not yet standard, and even these adaptations focus more on creating safety and reducing hyperarousal than on actively processing and resolving traumatic material.

Similarly, mindfulness does not directly challenge the pain-as-danger belief system. Pain neuroscience education explicitly teaches patients that pain in the absence of tissue damage is a protective output of a sensitized nervous system, not a signal of injury. This cognitive shift can powerfully reduce fear and support behavioral change. Mindfulness, by contrast, teaches observation and acceptance but typically does not provide a clear neurobiological explanation of why the pain is present. Patients are encouraged to "be with" the pain without trying to change it. For some, this is liberating. For others, it can feel passive or even collusive with the nervous system's mistaken belief that threat is present. Without an explicit reattribution of pain from damage to protection, acceptance can inadvertently reinforce the idea that pain is an inevitable, unchangeable reality rather than a learned pattern that can be unlearned.

From a Pain Resolution Therapy perspective, mindfulness has value as a tool for emotional regulation and for reducing the overlay of fear and catastrophizing that amplify pain. It can help patients develop the capacity to stay present with difficult emotions, which is essential when processing suppressed anger, grief, or shame. It can support parasympathetic activation and reduce autonomic arousal in the moment. These are not trivial contributions. But they are insufficient as a standalone treatment for chronic psychophysiologic pain because they do not systematically address the mechanisms maintaining sensitization.

Pain Resolution Therapy integrates some elements of mindful awareness—particularly the capacity to observe sensations and emotions without immediate reactivity—but places these within a larger, more targeted framework. Reattribution provides the cognitive scaffolding that mindfulness often lacks, teaching patients why their pain persists and what it represents. Emotional processing goes beyond mindful observation to active expression and integration of suppressed feelings. Conflict resolution identifies and addresses the specific inner dilemmas and role strains that maintain threat signals. Behavioral experiments provide concrete, real-world tests of new predictions, generating the kind of disconfirming evidence that passive observation alone cannot produce.

When mindfulness is used within this framework, it becomes more potent. A patient learning to express anger for the first time can use mindfulness to stay grounded and present during the emotional intensity of that expression. A person testing a new boundary can use mindful awareness to track bodily responses and notice that the feared catastrophe does not occur. In these contexts, mindfulness supports change rather than substituting for it.

For clinicians, the evidence on mindfulness suggests caution about overselling it as a primary solution. It is reasonable to offer mindfulness as one component of a comprehensive pain program, particularly for patients who find meditation practices intrinsically meaningful or who need support with emotional regulation. But when mindfulness is positioned as the central intervention for chronic pain, patients may spend months in practice with minimal change in pain or disability, wondering whether they are simply "not doing it right." This can add to demoralization and delay access to more targeted treatments.

The literature's emphasis on acceptance and quality of life as primary outcomes for mindfulness also deserves scrutiny. Acceptance and improved quality of life are valuable. But for many patients with chronic pain, particularly those with centralized, neuroplastic pain that is reversible, the goal is not only to accept pain more gracefully. It is to eliminate it by addressing the mechanisms that generate it. Mindfulness, as currently practiced and researched, is oriented more toward the former than the latter. It helps people live better with pain. Pain Resolution Therapy aims to help people live without it.

Why Suggestibility Limits Its Effectiveness

Hypnosis for Chronic Pain

Why top-down suggestion alone rarely resolves the underlying threat circuits.

0:00—

Hypnosis occupies a peculiar place in chronic pain treatment. On one hand, it is supported by a respectable body of research showing that, under the right conditions, hypnotic suggestions can reduce pain intensity in a range of acute and chronic pain conditions. Meta-analyses report small-to-moderate effects compared to standard care and education, and in some trials, hypnosis performs about as well as other psychological interventions. On the other hand, hypnosis remains marginal in most pain guidelines and is rarely offered as a core treatment in multidisciplinary programs. Many patients try one or two hypnosis recordings with little benefit and conclude that they "cannot be hypnotized." Others experience impressive short-term relief in a clinical or research setting, only to find that their pain returns once the session is over or life becomes stressful again.

To make sense of this, it is necessary to separate two questions. First, can hypnosis change pain perception? The answer, based on decades of experimental and clinical work, is clearly yes for a meaningful subset of people. Second, does hypnosis, as it is typically practiced, address the underlying mechanisms that maintain chronic psychophysiologic pain over months and years? Here the answer is more cautious. Hypnosis can be a useful adjunct for some patients, especially those who are highly responsive to suggestion and who use self-hypnosis consistently. But by itself, it does not usually resolve the deeper threat-detection patterns, emotional conflicts, and learned associations that drive central sensitization. Pain Resolution Therapy therefore views hypnosis not as a primary solution, but as one possible tool within a broader framework that explicitly targets the nervous system mechanisms keeping pain alive.

The empirical picture begins with the meta-analytic data. A landmark meta-analysis by Adachi and colleagues pooled 13 trials of hypnosis for chronic pain conditions and found that, compared with standard care, hypnosis produced a moderate treatment effect on pain. When hypnosis was compared with other psychological interventions, the picture was more nuanced. In some chronic pain groups, hypnosis showed a modest advantage over other therapies; in others, particularly headache, it did not. The authors concluded that hypnosis is efficacious relative to no treatment but its superiority over other active psychological interventions is not consistent. Subsequent reviews and scoping analyses have largely confirmed this pattern. Hypnosis reliably outperforms wait-list, education-only, and some attention controls, but when placed next to well-delivered cognitive-behavioral, acceptance-based, or pain education interventions, its advantage often shrinks or disappears.

More recent work has refined these conclusions and added an important detail about dose. A 2022 systematic review and meta-analysis focusing on chronic musculoskeletal and neuropathic pain examined the number of hypnosis sessions required to observe reliable effects. The authors found that protocols delivering fewer than eight sessions tended to yield small or statistically non-significant benefits, whereas treatments with eight or more sessions produced more consistent and clinically meaningful reductions in pain. This aligns with earlier recommendations by hypnosis researchers who suggested that "very brief" or "brief" hypnosis (seven sessions or fewer) is usually insufficient for chronic pain, and that a full hypnosis course should involve at least eight sessions with ongoing self-hypnosis practice. In other words, hypnosis is not a quick fix. Where it works, it tends to require a meaningful investment of time and repetition—something not always communicated clearly to patients who try one or two sessions or a recording and then understandably conclude it "doesn't work."

At the same time, not every study finds a simple dose–response curve. A randomized trial in chronic pain comparing two sessions of self-hypnosis plus home audio to eight therapist-led sessions found that both doses produced significant reductions in pain intensity, interference, and sleep disturbance, with no clear superiority of the longer protocol. Over half of participants in the hypnosis arms achieved at least a 30 percent reduction in pain intensity, and these benefits persisted at six-month follow-up. Intriguingly, in this study, neither hypnotizability scores nor amount of home practice correlated strongly with outcome, raising questions about how much hypnotic depth and practice truly matter in some chronic pain populations. More broadly, the heterogeneity of hypnosis protocols, patient groups, and outcome measures across trials makes it difficult to define an exact "minimum effective dose" for every condition.

Despite these complications, there is broad agreement on one robust moderator of hypnotic analgesia: hypnotic suggestibility. Hypnotic suggestibility—or hypnotizability—is a stable individual difference in how strongly a person responds to hypnotic suggestions. It is usually measured with standardized scales such as the Stanford Hypnotic Susceptibility Scales or the Harvard Group Scale. Across large normative samples, roughly 10 to 15 percent of people score in the "high" range, another 10 to 15 percent score "low," and the remaining 70 to 80 percent fall in the medium range. High hypnotizable individuals can experience vivid alterations in perception, memory, and voluntary control in response to suggestion; low hypnotizable individuals show few such changes even under optimal conditions.

A comprehensive meta-analysis of 85 controlled experimental studies on hypnosis and pain found that hypnotic suggestibility and the use of direct analgesic suggestions were key determinants of effect size. In conditions of experimentally induced pain, high suggestible participants receiving direct analgesic suggestions experienced, on average, around 40 percent reductions in pain, with medium suggestibles showing roughly 30 percent reductions. Low suggestible participants showed minimal improvements. These data underscore a critical point: hypnotic analgesia is not a uniform phenomenon. It is driven disproportionately by a minority of the population with high hypnotic responsiveness. For others, especially those in the low range, hypnosis is less potent as a stand-alone analgesic.

Clinical samples show similar trends, although the relationships are sometimes weaker due to small samples and methodological variability. Studies in chronic musculoskeletal pain, fibromyalgia, and other persistent conditions suggest that patients who score higher on hypnotizability scales are more likely to benefit from hypnosis-based pain interventions, particularly when the treatment emphasizes direct analgesic suggestions and sensory modulation. However, many clinical trials do not measure hypnotizability at all, making it difficult to know whether null results reflect a genuinely ineffective protocol or a sample with few highly responsive individuals.

From a Pain Resolution Therapy perspective, this reliance on suggestibility reveals a structural limitation of hypnosis as a primary treatment. If a method requires that a person fall into the top 10 to 15 percent of hypnotic responsiveness to obtain the most robust analgesic effects, then by definition it will leave a large proportion of chronic pain patients with modest or inconsistent benefit. For a technique to be a core, scalable intervention, it must work reliably across the full spectrum of nervous system profiles, not only for those who can easily experience dramatic shifts under suggestion.

A second limitation, related to mechanism, is that hypnosis mainly acts at the level of perception and meaning in the moment of suggestion. Neuroimaging studies show that hypnotic analgesia can reduce activity in primary and secondary somatosensory cortices and modulate regions such as the anterior cingulate cortex and prefrontal areas involved in pain processing and attention. When a highly hypnotizable person is guided to imagine their pain as distant, cool, or turned down on a dial, corresponding changes in brain activity can indeed make the pain feel less intense or less unpleasant. This is an impressive demonstration of top-down modulation. However, in standard protocols, these changes are typically transient. They occur during or shortly after sessions and then gradually fade unless suggestions are frequently reinforced through self-hypnosis.

What hypnosis does not typically do, by itself, is systematically identify and resolve the ongoing sources of threat that keep the nervous system in a sensitized state. Chronic psychophysiologic pain is rarely maintained solely by the brain's raw capacity to amplify or dampen sensation. It is driven by prediction: the nervous system has learned that certain movements, contexts, emotions, and internal conflicts signal danger, and it responds with protective pain. Pain is being generated not only because the person can be told that their hand feels cold and numb, but because their life repeatedly evokes unresolved dilemmas—duty versus rest, authenticity versus approval, anger versus peace-keeping—that their nervous system has encoded as high stakes. In that context, hypnotic suggestion may shift the volume of pain temporarily, but it does not change the underlying "reasons" the system keeps predicting threat.

To put it differently, hypnosis is excellent at saying to the pain system, "Turn down the signal now." It is less equipped, in its standard form, to ask, "Why is this signal being sent in the first place, and what new experiences would convince the system to stop sending it?" Many hypnotherapists, of course, attempt to work with root causes. They may use regression techniques to revisit past events, suggest new meanings for old experiences, or symbolically "release" emotional burdens. Yet these approaches, while powerful for some individuals, are typically unstructured, idiosyncratic, and not explicitly grounded in contemporary models of central sensitization, predictive coding, or the Inner Conflict Circuit.

There is also the question of generalization. A person may learn, in trance, to imagine turning down a pain dial or numbing a limb. This can be very helpful in coping with flares or medical procedures. But if, outside trance, they continue to overwork past their limits, suppress anger to keep the peace, or live inside "I have no choice" roles, the nervous system remains saturated with threat signals. In that situation, using hypnosis to mute pain can sometimes function as a sophisticated avoidance strategy, allowing the person to endure an unsustainable life pattern a little longer without addressing the conflicts driving their sensitization. From a Pain Resolution Therapy standpoint, the goal is not simply to increase capacity to tolerate an impossible life, but to help the person change the life conditions and internal rules that make pain necessary as protection.

A third limitation concerns how hypnosis fits within evidence-based care pathways. Major guidelines and health system reviews of psychotherapies for chronic primary pain list cognitive-behavioral, acceptance-based, and certain emotionally focused protocols as first-line psychological interventions. Hypnosis is generally mentioned, where it is mentioned at all, as an adjunctive or optional treatment—not as a core pathway. An umbrella review of psychological interventions for pain reduction notes that while hypnosis shows promising effect sizes, the overall quality of evidence and consistency across conditions are lower than for more fully developed, manualized therapies. A recent high-quality review of adjunctive hypnosis concluded that hypnosis added to education or usual care can yield a medium additional reduction in chronic pain intensity, but that adding hypnosis to already-effective psychological interventions produces at most small, delayed benefits and sometimes no immediate additional gain.

This positioning matters when designing a treatment model like Pain Resolution Therapy. The question is not whether hypnosis ever helps; it clearly does for some. The question is whether it should be placed at the center of a psychophysiologic pain program or used, if at all, in a supporting role for selected patients. Given the reliance on suggestibility, the need for multiple sessions, and the limited evidence that hypnosis alone reorganizes the deeper conflict and threat circuits that PRT targets, it is more coherent to treat hypnosis as a technique rather than a core mechanism of change.

Pain Resolution Therapy instead organizes its work around mechanisms that are present in virtually all chronic pain patients, regardless of hypnotic responsiveness: learned threat predictions, chronic internal role conflicts, suppressed or unintegrated emotional states, and behaviors that confirm the nervous system's expectation that the body is unsafe. Tools are chosen based on their ability to alter these mechanisms reliably. Behavioral experiments, emotional processing, conflict mapping, and cognitive reattribution operate by feeding the nervous system new, disconfirming evidence about threat in real-life contexts. They are not dependent on a trance state or on being in the top decile of suggestibility. They can incorporate imagery, focused attention, and even light hypnotic techniques where helpful, but they do not rely on hypnosis as such.

None of this means hypnosis has no place. For highly responsive patients who enjoy hypnotic work and are willing to practice self-hypnosis regularly, hypnotic analgesia can be a useful complement. It can provide immediate relief during flares, support relaxation and sleep, and create experiential windows in which it is easier to approach feared sensations or emotions. It can also, when integrated thoughtfully, become one of several ways to retrain the brain's predictions: suggestions can be tailored not just to "turn down" pain but to reinforce safety during movement, boundary-setting, or emotional expression. The difference is that, within Pain Resolution Therapy, these suggestions would be embedded inside a larger, explicitly mechanistic framework rather than relied on as the main driver of change.

In summary, hypnosis demonstrates that top-down modulation can powerfully influence pain, but its effectiveness is constrained by the distribution of hypnotic suggestibility in the population, by the need for sufficient dosage, and by its traditional focus on symptom modulation rather than on resolving the conflicts and threat patterns that sustain central sensitization. For a subset of patients—especially those who are highly hypnotizable and who engage in enough sessions—hypnosis can be an important adjunct. For many others, it will offer at best modest, temporary relief unless coupled with a broader program that addresses why the nervous system is overprotecting in the first place. Pain Resolution Therapy locates hypnosis, when used, as one of several tools in a toolbox whose primary task is not to distract from pain, but to convince a vigilant nervous system, through lived experience, that it can safely stand down.

Why Biomechanical Approaches Take Forever Without Addressing the Brain

Physiotherapy is Too Slow

Why structural fixes often fail to resolve a sensitized nervous system.

0:00—

Physiotherapy is one of the most trusted and widely used treatments for chronic pain. Patients are referred to physiotherapists for back pain, neck pain, shoulder problems, fibromyalgia, temporomandibular disorders, and a host of other musculoskeletal complaints. The logic is straightforward: if pain is in the body, then improving mechanics—strengthening weak muscles, stretching tight tissues, mobilizing stiff joints, correcting posture—should reduce pain. This approach makes sense when pain is closely tied to clear structural pathology or recent injury. But in chronic pain, where central sensitization and predictive brain mechanisms play a central role, purely biomechanical treatment often leads to slow, modest gains that plateau long before patients reach meaningful relief.

The research literature reflects this clinical reality. Systematic reviews of exercise and physical therapies for chronic low back pain, one of the most studied chronic pain conditions, consistently find only small to moderate effects. A large review of physical and rehabilitation interventions for chronic low back pain concluded that exercise therapy is slightly more effective than usual care for reducing pain and disability in the short term, and that multidisciplinary programs that combine exercise with behavioral components produce somewhat larger effects. The overall quality of evidence, however, was low to moderate, and effect sizes were generally small. Another analysis of exercise programs for chronic low back pain found that while exercise can improve pain and function for up to six months after treatment, the average benefit is modest and highly variable across individuals.

More granular data from clinical trials reveal the same pattern. Typical physiotherapy programs for chronic spinal pain involve 6 to 12 weeks of supervised exercise, manual therapy, and home exercise instruction. Studies that extend treatment to 6 or even 12 months report gradual improvements in function and small reductions in pain, but few patients become pain-free, and many continue to report substantial symptoms. Manual therapy, including spinal manipulation and mobilization, offers significant short-term pain reduction in chronic nonspecific low back pain, but like most interventions for chronic low back pain, its effects tend to diminish over time and are not clearly superior to other active treatments. In other words, traditional physiotherapy can help, but it often takes a long time and yields only partial relief when applied as a purely biomechanical intervention.

To understand why, it is essential to recall that chronic pain is rarely a simple mechanical problem. In central sensitization, the central nervous system undergoes structural, functional, and chemical changes that make it more sensitive to input from the body. The dorsal horn of the spinal cord becomes hyperexcitable. Supraspinal regions involved in pain modulation, such as the anterior cingulate cortex, insula, and prefrontal cortex, change their connectivity and responsiveness. Descending inhibitory systems weaken, while facilitatory pathways strengthen. The result is a nervous system that reacts to normal movement and loading as if it were threatening, generating protective pain signals even in the absence of ongoing tissue damage.

In this context, movement-based interventions are still crucial, but not for the reasons originally assumed. Exercise and physical activity can reduce pain and improve function, not primarily by "fixing" structural faults, but by altering brain and spinal cord processing. Experimental and clinical work shows that exercise activates the brain's mesocorticolimbic reward system, including dopamine neurons in the ventral tegmental area and projections to the nucleus accumbens. This activation can normalize limbic function, counteracting the reduced motivation, anhedonia, and fear-avoidance patterns common in chronic pain. Exercise also engages positive neurons in the basolateral amygdala that support goal-directed behavior and fear extinction, helping patients overcome learned associations between movement and danger.

A 2023 review of exercise therapy for chronic pain describes how graded physical activity can suppress fear conditioning and reshape brain networks, supporting the creation of new, non-painful movement memories. This aligns with clinical observations: when patients perform feared movements in a graded, safe, and repeated way, their nervous systems gradually relearn that these movements are not harmful. Pain decreases, not because the disc has been "put back in" or the posture has been perfectly corrected, but because the brain's prediction of threat attached to that movement has been updated.

However, when physiotherapy focuses narrowly on biomechanical corrections—pelvic alignment, scapular positioning, segmental stabilization—without explicitly addressing the brain's role, several problems arise. First, treatment plans often assume a direct line from structural change to symptom change: if the muscle becomes stronger or the joint more mobile, pain will naturally follow. In chronic centrally sensitized pain, this assumption is inaccurate. A patient can demonstrate objectively improved strength, flexibility, and motor control on testing and still report high levels of pain. Clinicians interpret this as "they must need more time" or "they are not doing their exercises," leading to extended courses of therapy that incrementally improve function but leave the core pain experience largely unchanged.

Second, without addressing fear, beliefs, and nervous system sensitivity directly, exercise can easily provoke flares that reinforce pain memories. Many patients with centralized pain describe a "boom–bust" cycle: after a good day, they push harder in therapy or daily life, only to experience a severe flare that confirms their belief that movement is dangerous. Reviews on central sensitization emphasize that patients are often told to "exercise" without adequate guidance on pacing, graded exposure, or how to understand pain spikes. When patients interpret flares as signs of damage rather than evidence of a sensitive, plastic system, they become more fearful and avoidant. In that context, adding more sets or adjusting posture tweaks the mechanics but does not alter the underlying threat assessment.

Third, purely biomechanical approaches do not typically engage with the emotional and relational dimensions of pain. A patient with chronic low back pain may unconsciously brace their lumbar muscles whenever they feel guilt about resting, fear about being judged as lazy, or anger about unequal caregiving burdens. Their movement patterns are not only responses to physical loads; they are shaped by the Inner Conflict Circuit: duty versus rest, self-protection versus loyalty, authenticity versus approval. Without identifying and addressing these conflicts, physiotherapy may inadvertently collude with them, reinforcing over-responsibility and self-neglect under the banner of "compliance."

When physiotherapy is integrated with pain neuroscience education and, ideally, with emotional processing, the picture changes. Pain neuroscience education (PNE) is an educational approach that helps patients understand pain as a protective output of the nervous system rather than a direct measure of tissue damage. It explains central sensitization, neuroplasticity, and the role of thoughts, emotions, and context in shaping pain. Systematic reviews and meta-analyses show that PNE, when combined with exercise or other physical therapy modalities, significantly reduces pain and disability in chronic pain populations compared with physical therapy alone.

A 2025 systematic review and meta-analysis of 19 randomized clinical trials found that programs combining PNE with physiotherapy reduced mean pain intensity from 5.89 to 3.03 on a 0–10 scale and produced similar improvements in disability scores. The authors concluded that PNE plus physiotherapy is more effective than physiotherapy alone and recommended that education not be offered in isolation but integrated with therapeutic exercise. Earlier meta-analyses focused on chronic low back and spinal pain reached similar conclusions: PNE combined with exercise yields greater improvements in pain, disability, catastrophizing, and kinesiophobia than exercise or manual therapy alone.

Dose–response data provide further nuance. A 2024 dose–response meta-analysis of PNE plus exercise for chronic spinal pain analyzed 26 randomized controlled trials with 1,852 patients. The researchers found that adding approximately 200 minutes of PNE to an exercise program produced pain reductions exceeding the minimum clinically important difference by about 2.6 points on a 0–10 scale, and that adding around 150 minutes of PNE produced clinically meaningful improvements in disability. In contrast, the pooled effect of exercise alone on pain intensity was minimal. This suggests that exercise becomes a much more powerful tool for chronic pain when the brain understands why it is being asked to move and when movement is framed explicitly as safe despite sensitivity.

Individual trials echo these findings. A multicenter randomized clinical trial in primary care compared a program combining six sessions of PNE with group physical exercise (18 sessions over six weeks) against usual physiotherapy for chronic spinal pain. The combined intervention was superior at post-treatment and follow-up for quality of life, pain intensity, catastrophizing, kinesiophobia, disability, and measures of central sensitization. Another trial in temporomandibular disorders is currently evaluating physiotherapy alone versus physiotherapy plus PNE, with outcome measures including pain, disability, self-efficacy, catastrophizing, kinesiophobia, and central sensitization indices. The very design of such trials reflects the emerging consensus that addressing the brain and beliefs is not optional—it is central to making physiotherapy effective for chronic pain.

Beyond education, integrating emotional processing with movement work further enhances outcomes. Exercise therapists and physiotherapists working within modern pain frameworks increasingly apply graded exposure in vivo principles during exercise sessions. Instead of merely prescribing sets and reps, they identify feared movements and pair them with safety cues, humor, social support, and explicit processing of fear and avoidance. This targets the amygdala-centered circuits that store pain-related fear memories. When a patient squats, bends, or lifts while noticing and tolerating fear, and then experiences no damage, a powerful prediction error is generated. Over time, these experiences rewrite pain memories more effectively than mechanical adjustments alone.

From a Pain Resolution Therapy standpoint, physiotherapy is most effective when it is invited into a broader neuroplasticity-based framework. Movement is a primary way the nervous system learns, but what it learns depends on context. If movement occurs under the rule "I must push through or I am weak," with unacknowledged anger and resentment, the nervous system may interpret it as further threat and keep sensitization high. If movement occurs under the understanding "My body is safe but sensitive," in the context of resolved or resolving inner conflicts and processed emotions, it becomes an opportunity for the nervous system to update its threat assessment.

Pain Resolution Therapy's reattribution work prepares patients for this kind of physiotherapy. When patients understand that their pain reflects a protected, not a damaged, body, they can engage in graded exercise without interpreting every flare as harm. The emotional processing component addresses the anger, grief, and fear that otherwise show up as bracing, guarding, and non-verbal "no" in the muscles. Conflict resolution helps patients change the roles and rules that drive overuse—say, reducing unsustainable caregiving or perfectionism—so that exercise truly supports, rather than fights against, their nervous system's need for safety.

In this context, movement becomes a form of behavioral experiment: a way of testing new beliefs and new emotional positions in the body. A patient who has always moved under the belief "If I rest, I am lazy" might, after PRT conflict work, choose to do fewer, more targeted exercises while checking in with their body rather than punishing it. Another who has always guarded their back in fear might practice relaxed, fluid movements while naming out loud, "I am safe, my spine is strong," and noticing that the predicted disaster does not occur. Each of these experiences teaches the brain something pharmacology and passive modalities cannot: that the world, and the body, are less dangerous than the nervous system had learned.

None of this diminishes the skill and value of physiotherapists. On the contrary, it highlights their central role in delivering the experiential component of neuroplastic pain treatment. But it does require a shift away from purely biomechanical models and toward integrated, brain-based practice. Physiotherapists who continue to work exclusively on "alignment," "instability," or "muscle imbalance" without addressing central sensitization, fear, beliefs, emotional context will continue to see what the literature shows: slow progress, modest gains, and frequent plateaus.

By contrast, when physiotherapy is combined with pain neuroscience education and aligned with the emotional and conflict-resolution work of Pain Resolution Therapy, it becomes a powerful vehicle for change. Movement is no longer just a means of strengthening or stretching; it is a language through which the nervous system can be taught that threat has passed. In that setting, gains do not have to take forever, and improvements are more likely to be both meaningful and sustainable.

How Social Context Shapes the Threat Response

Cultural, Gender, and Identity Factors

How social context and identity shape the nervous system's threat response.

0:00—

Pain Resolution Therapy proposes that chronic pain is often maintained by unresolved emotional conflicts and by internal dilemmas around roles, boundaries, and authentic expression. This is a powerful and clinically useful framework. But there is a risk, inherent in any psychological model, that "resolution" will be implicitly defined by the values, norms, and privileges of the people who developed it. What if the culture in which a person lives does not endorse open anger? What if setting a boundary might genuinely endanger them? What if the role they are in is not optional, and survival depends on maintaining it? Pain Resolution Therapy does not claim to be culture-neutral or universally applicable in a one-size-fits-all way. Instead, it recognizes that emotional expression rules, acceptable role behaviors, and the real consequences of conflict or boundary-setting vary profoundly across cultures, genders, social classes, and marginalized identities. To be ethical and effective, the framework must adapt to these contexts without abandoning its core insight that unprocessed emotions and irresolvable conflicts can maintain pain.

Gender is one of the most fundamental contexts shaping how people experience and express pain. Women are statistically overrepresented in chronic pain conditions such as fibromyalgia, chronic pelvic pain, migraine, and irritable bowel syndrome. This is not coincidental. Adverse childhood experiences, including sexual abuse, physical abuse, and emotional neglect, are more common in women with chronic pain than in men, and the pain-relevant effects of trauma are more pronounced in female populations. Gender socialization plays an equally important role. In many cultures, girls and women are trained to prioritize others' needs, to suppress anger as "unladylike," to endure rather than complain, and to maintain relational harmony at personal cost. These patterns fit precisely with the Inner Conflict Circuit model: chronic oscillation between duty and self-care, between authenticity and approval, between suppressed anger and peace-keeping.

When Pain Resolution Therapy works with women, these gendered patterns often emerge as central themes. A patient may report lifelong training that "good girls" do not get angry, that expressing needs is selfish, or that their worth is measured by how much they sacrifice. Therapists must take care not to pathologize these patterns as individual deficits. They are adaptive responses to social structures that punish assertiveness and reward self-erasure in women. The goal is not to tell a woman she "should" be more assertive or "should" set better boundaries, as if these actions carry no cost. Instead, the work becomes identifying what authentic choices are possible within her actual constraints and exploring, with her, the emotional and relational costs of various options—including the cost of continuing to suppress her own needs indefinitely.

For some women, small boundary experiments will be realistic and will begin to shift the pain pattern. For others, especially those in economically dependent relationships or environments where direct resistance carries physical or social risk, changes may need to be more internal at first: recognizing anger without yet expressing it aloud, grieving losses without requiring immediate action, or building support networks outside the main conflict zone. Pain Resolution Therapy frames resolution as reaching a "workable position" the person can live with, not as achieving a Western ideal of total autonomy. It validates that sometimes the most workable position is strategic suppression combined with harm-reduction measures, while acknowledging that this partial resolution may limit how much pain can improve.

Men face different, though also constraining, socialization. Many are taught that emotional vulnerability is weakness, that pain should be endured silently, that seeking help is shameful, and that anger is the only acceptable "negative" emotion. These rules narrow the emotional repertoire in ways that can maintain pain. A man with chronic back pain may insist he is not stressed or emotional, framing his pain purely in mechanical terms, while his life is saturated with suppressed grief, fear of failure, or rage at powerlessness. Therapists working within Pain Resolution Therapy must be prepared to meet patients where they are, respecting the cultural codes that make emotional disclosure feel unsafe, while gradually creating space where vulnerability can be explored without shame.

In some cases, this means avoiding explicitly emotional language early on. Instead of asking, "How does that make you feel?" a therapist might ask, "What do you notice in your body when you think about that situation?" or "If your back could talk, what would it say?" Somatic entry points can be less threatening than direct emotional labeling for individuals whose identity has been built around stoicism. Over time, as trust builds, fuller emotional expression may become possible. But therapists must resist imposing a timeline or judging a patient's caution. For men in contexts where vulnerability invites social or economic punishment, moving slowly is not resistance. It is wisdom.

Cultural contexts beyond gender add further complexity. Many cultures view open expression of anger, especially toward elders or authority figures, as deeply disrespectful or morally wrong. In collectivist societies, prioritizing individual needs over family or community obligations may be seen not as healthy boundary-setting but as selfishness or betrayal. In these contexts, the Inner Conflict Circuit operates within tighter constraints. A person may be genuinely unable to say no to a parental demand without facing social ostracism, loss of family support, or profound guilt that their moral framework labels as justified rather than neurotic.

Pain Resolution Therapy does not claim that every conflict can be resolved or that every suppressed emotion should be immediately expressed. Instead, it acknowledges that real trade-offs exist. The therapeutic task becomes helping the patient see their options clearly, including options that do not conform to a Western model of individuation. For example, a patient from a culture that values filial piety might reach a resolution not by reducing contact with a demanding parent but by finding ways to fulfill the role with less internal war: accepting that duty is a genuine value for them, seeking support to make the role less isolating, or creating small pockets of autonomy in other life domains. If this reduces the sense of being trapped and lowers nervous system vigilance, pain may still improve, even without dramatic external change.

Race and ethnicity introduce additional layers. People of color, especially Black and Indigenous individuals in countries with histories of colonization and enslavement, live with the chronic threat of systemic racism, microaggressions, police violence, and healthcare discrimination. These are not abstract psychological stressors. They are real threats that the nervous system registers and responds to with vigilance. Chronic exposure to racial trauma produces physiological consequences similar to other forms of chronic threat: HPA axis dysregulation, elevated inflammatory markers, allostatic load, and increased rates of chronic pain. When a Black patient presents with chronic pain, it is inadequate to focus only on individual emotional conflicts or family dynamics without acknowledging the societal context of racialized danger.

Pain Resolution Therapy, applied in a culturally responsive way, must name these realities and validate them as genuine sources of threat. A therapist might explore: "How does your pain behave on days when you have experienced racism or discrimination? Do you notice flares after interactions where you had to suppress your anger to stay safe?" This frames racialized stress not as the patient's problem to fix internally but as an external threat to which their nervous system is understandably responding. Resolution work may then include not only processing suppressed anger and grief but also building community, engaging in activism, or finding contexts where the person can be seen and safe. Crucially, the therapist must avoid placing the burden of "resolution" entirely on the individual. When the conflict is between authentic self-expression and real physical or economic danger, there is no fully safe resolution until the external structures change.

Healthcare discrimination itself is a source of chronic threat for many marginalized patients. Women, people of color, LGBTQ+ individuals, and people with disabilities report being dismissed, disbelieved, or subjected to biased treatment in medical settings. For chronic pain patients, this often means being told their pain is "not that bad," being denied adequate investigation or treatment, or being labeled as drug-seeking. These experiences teach the nervous system that the healthcare system is not safe. When such a patient arrives at Pain Resolution Therapy, mistrust may be high. The therapist's first task is to earn credibility by listening deeply, validating the patient's experiences, and acknowledging systemic failures explicitly rather than pretending neutrality.

Gender identity and sexual orientation add further dimensions. Transgender and non-binary individuals experience chronic pain at higher rates than cisgender populations. Proposed mechanisms include minority stress, experiences of rejection and violence, challenges accessing affirming healthcare, and in some cases physiological effects of gender-affirming treatments. Many also carry histories of familial rejection, which fit centrally into the Pain Resolution Therapy model: the Inner Conflict Circuit between being true to oneself and maintaining family connection. For these patients, pain may function as a messenger about irreconcilable identity-based conflicts or as a somatic marker of chronic vigilance in a society that treats their existence as contested.

Pain Resolution Therapy can offer a framework for understanding these experiences without pathologizing identity. A therapist might work with a transgender patient to identify how pain flares around family gatherings where their identity is denied, or in healthcare settings where they are misgendered. Emotional processing might include grief about lost family relationships, anger at systemic transphobia, and fear about safety. Conflict resolution might focus on negotiating boundaries with unsupportive family members or finding affirming community. Importantly, the therapist does not frame gender identity as the problem. The problem is the relational and societal context that creates irresolvable conflict around that identity. As patients build lives more aligned with their authentic selves and find communities where they are seen, pain often improves—not because they have "fixed" themselves, but because the chronic threat of invalidation decreases.

Class and economic precarity similarly shape what is possible. A person in chronic pain who is working multiple jobs to survive, who lacks healthcare access, or who cannot afford to miss work may face conflicts where no option is workable. Rest means no income. Continuing to work means worsening pain. Leaving a toxic job means loss of health insurance. Pain Resolution Therapy cannot pretend that individual emotional work alone will resolve conflicts rooted in structural inequality. What it can do is help the person see their situation clearly, grieve what is not available to them, make the most strategic choices within real constraints, and build solidarity and support. Even when pain cannot be fully eliminated because external threats remain active, reducing the internal war and the shame about not coping better can sometimes lower symptom severity and improve quality of life.

For therapists, this means practicing with humility and flexibility. It means asking about cultural and social context early and often. It means not assuming that a given conflict, role, or emotion has the same meaning across identities. It means recognizing when pain is a response to genuine ongoing threat—societal, economic, relational—and not only to past trauma or internal patterns. It also means being willing to say, "Your pain makes sense given what you are living with," and to acknowledge when the therapeutic framework cannot address the root causes alone.

At the same time, Pain Resolution Therapy's core mechanisms remain valuable across contexts. Reattribution—understanding that pain is a brain-generated signal of protection—is relevant whether the threat is a disc bulge, an unresolved conflict, or systemic oppression. Emotional processing—accessing and expressing suppressed feelings—is relevant whether those feelings are anger at a parent or rage at a racist system. Conflict resolution—moving from "no choice" to "chosen path"—is relevant whether the dilemma is personal or structural, though the available choices and the meaning of resolution will differ. By grounding the work in each patient's lived reality and honoring the constraints they face, Pain Resolution Therapy can adapt its methods without losing its neurobiological foundation.

Ultimately, addressing cultural, gender, and identity factors in Pain Resolution Therapy is not about adding a chapter on "special populations." It is about recognizing that all pain occurs in context, that all emotional expression rules are cultural, and that all conflicts are shaped by power. A framework built to address the emotional and relational drivers of pain must account for the fact that what counts as threat, what emotions are safe to feel, and what choices are possible vary profoundly depending on who you are and where you are situated. By remaining flexible, critically aware, and committed to listening, therapists can use Pain Resolution Therapy's insights to serve diverse populations while avoiding the trap of imposing a single, culturally narrow vision of health.

What we know about chronic pain, and what to do with it.

Global Chronic Pain Crisis

The Predictive Brain

The Knowing–Doing Gap

Pain Medications

Psychoanalysis: The Missing Action Component

Central Sensitization

Inner Conflict Circuit

Adverse Childhood Experiences and Chronic Pain

Why CBT Doesn't Resolve Psychosomatic Pain

Mindfulness for Chronic Pain: Nearly Useless

Hypnosis for Chronic Pain

Physiotherapy is Too Slow

Cultural, Gender, and Identity Factors

Get Out of My Office

The research is the foundation. The program is what you do with it.